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Abstract 
Previous research indicates loneliness affects physiological and quality of life outcomes in 
oncology populations. However, minimal research has been conducted specifically on bone and 
blood marrow transplant (BMT) patients (Knight et al., 2013). To further explore this issue, we 
conducted a preliminary study to examine the relationship of loneliness with quality of life, 
immunological functioning, and other health indicators at six months post-transplant in BMT 
patients. The Functional Assessment of Cancer Therapies-BMT (FACT -BMT) was used to 
measure QOL and the UCLA Loneliness Scale Version 3 was used to assess general loneliness 
and loneliness experienced during hospitalization. We found that experiencing loneliness during 
hospital stay and experiencing loneliness in general was negatively associated with overall 
quality of life six months after a BMT. Specially, hospital loneliness was associated with poorer 
social well-being and poorer functional well-being; and loneliness in general was associated with 
poorer social well-being. In addition, loneliness during hospitalization was related to difficulty 
managing disease symptoms six-months after a transplant. Hospital loneliness was associated 
with higher neutrophil counts to monocyte counts 30 days after BMT, which is an indicator of 
poorer overall survival rate. However, loneliness during hospital stay was not associated with 
neutrophil to lymphocyte ratio. These results indicate that there is a relation between loneliness 
experienced during hospitalization and immunological functioning which may adversely impact 
recovery from a bone marrow transplant. 
Keywords: loneliness, oncology, bone marrow transplant, health outcomes, immune 
components 
LONELINESS IN BONE MARROW TRANSPLANT PATIENTS 
Due to a Bone Marrow Transplant, Is Loneliness from Hospital Isolation a Predictor of Health 
Outcomes? 
A bone manow transplant (BMT) is an arduous medical procedure which carries a high 
risk of mortality and morbidity post-transplant due to health complications and isolation. In 
comparison to other oncology populations, there is minimal research that determines the 
relations between immune function, psychosocial factors, and clinical outcomes in BMT 
populations. These relationships may be significant due to the importance of prompt immune 
recovery and immune regulation in preventing infections and reducing morbidity and mortality 
(Costanzo, Juckett, & Coe, 2013). Costanzo et al. (2013) suggests that potential mechanisms of 
psychosocial factors influence immune processes which are relevant to post bone manow 
transplant outcomes. Stable social support throughout the transplant process has been linked to 
positive health outcomes (Frick, Rarnm, Bumeder et al., 2006; Lim & Zebrack, 2006; Rodrigue, 
Pearman, & Moreb, 1999) as well as predicts overall survival, higher quality of life, decreased 
depression rates, and decreased psychosocial morbidity (Cooke, Gemmill, Kravits, & Grant, 
2006; Grassi, Indelli, Marzola et al., 1996; Jacobsen, Sadler, Booth-Jones et al., 2002; Jenks 
Kettmann & Altmaier, 2008; Lloyd-Williams & Friedman, 2001; Rodrigue et al., 1999; Widows, 
Jacobsen, Booth-Jones et al., 2005). 
Loneliness and Social Connection 
Loneliness is experienced throughout the general population, gradually diminishing 
during middle adulthood and increasing again around the age of 70 (Heinrich & Gull one, 2006; 
Pinquart & Sorensen, 2001; Theeke, 2009; Weeks, 1994). Despite varying loneliness definitions, 
'" 
all share three major themes in that loneliness involves: (1) inadequate social relationships, (2) 
personal experience, and (3) distressing and unpleasant experience of loneliness (Peplau & 
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Perlman, 1982, p. 3). In their study, Peplau and Perlman (1982) focus on the concept of 
loneliness as a distressing feeling that accompanies the perception that one's own social needs 
are lacking in quantity and quality (Hawkley & Cacioppo, 2010). Similar to perceived social 
isolation, individuals who live relatively lonely lives may not experience loneliness; however, 
individuals who appear to have active social lives may experience feelings of loneliness 
(Pinquart & Sorensen, 2001). Experiencing loneliness has evolved as a signal for behavior 
change, similar to hunger, thirst, or physical pain, with individuals motivated to maintain and 
form intimate social connections (Cacioppo & Hawkley, 2009 & Cacioppo et al., 2006). 
2 
Social connections and relationships are fundamental components to positive 
psychological and physical wellbeing (Cacioppo et al., 2000). According to the Evolutionary 
Model conceptualized by Cacioppo and Hawkely (2005), unsafe feelings arise when an 
individual experiences loneliness. These feelings stimulate the survival mechanism, intensifying 
the sensitivity to threats from all types of relationships. This embedded survival instinct focuses 
on threats that initiate anxiety and detrimental interactions, allowing individuals to reduce short 
term damage of undesirable interactions. However, there is a risk of self-defeating hostility with 
individuals finding personal fault and blame (Cacioppo & Hawkley, 2005; Rotenberg, 1994). 
When experiencing loneliness, greater susceptibility to threats, rejection, and feelings of 
insecurity may occur. 
Loneliness is associated with social withdrawal, depression, shyness, pessimism, 
alienation, and low positive affect (Ernst & Cacioppo, 1999). Moreover, lonely individuals are 
more likely to have poorer social skills, reduced social support, lower surgency, lower emotional 
stability, and lower conscientiousness. In addition, loneliness has been found to be related to fear 
of negative evaluation, higher anxiety, negative mood, and anger (Cacioppo et al., 2006). 
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According to Cacioppo, Hawkley, & Thisted (2010) loneliness predicts depressive symptoms, 
however depressive symptoms do not predict loneliness. 
As individuals create better social connections they begin to alleviate the sense of threats 
and social pain, allowing true relations to form with others. In being open and socially 
connected, a creation of genuine connection and real relationships might arise for an individual. 
When feelings of sociality are satisfied, free of social pain, individuals experience better health. 
Moreover, feelings of connection reduce agitation, stress, and generally alleviates hostile feelings 
and depression, affecting health in positive ways (Cacioppo & Patrick, 2009). 
Loneliness and Health 
The Loneliness Model (Cacioppo & Hawkley, 2009; Cacioppo, Hawkley, Ernst et al., 
2006) incorporates the Evolutionary Model by Cacioppo and Hawkely (2005) and wherein they 
stated that perceived social isolation is similar to feeling unsafe, beginning a cycle of social 
threat feelings to the environment. Accordingly, lonelier individuals view their surroundings as 
more threatening, expecting greater undesirable social interactions, and recalling greater 
undesirable social information. Negative and undesirable social expectations have a tendency to 
provoke behavior in others that confirms the negative social expectations of lonelier individuals. 
These expectations initiate a self-fulfilling prophecy whereby lonely people purposely detach 
from potential social relations due to the belief that social distancing is attributable to others and 
surpass one's own control (Newall, Chipperfield, Clifton et al., 2009). Unfortunately, this loop 
of self-reinforcement is accompanied by feelings of anxiety, hostility, low self-esteem, 
pessimism, and stress (Cacioppo & Hawkley, 2009) which exemplifies a dispositional tendency 
<:"<I 
that stimulates behavioral and neurobiological mechanisms that contribute to undesirable health 
outcomes (Hawkley & Cacioppo, 2010). 
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Social isolation has been related to adverse impacts on health and well-being (Alpass & 
Neville, 2003; Berkman, 1995; Freyne, 2005; Hawton, 2010; MuCulloch, 2001). Specifically, 
social isolation and loneliness are associated with poorer physical well-being, mental health 
(Cacioppo et al., 2000; Ernst & Cacioppo, 1999; Lui, 2007; Perkins, 1991), personality disorders, 
psychoses (DeNiro, 1995; Richman, & Sokolove, 1992;), impaired cognitive functioning, 
cognitive decline over time (Gow et al., 2007; Tilvis et al., 2004; Wilson et al., 2007), and 
increased depressive symptoms (Cacioppo, et al., 2006; Heikkinen & Kauppinen, 2004; Segrin, 
1999; Wei, Russell, & Zakalik, 2005). Overall, having a poor social network and experiencing 
high levels of loneliness are related to poorer quality of life (Ekwall, Sivberg, Hallberg, 2004). 
Loneliness appears to have a significant impact on physical well-being which has been linked to 
immune stress responses and worse cognition over time (Luanaigh & Lawlow, 2008). 
In a study conducted by Cacioppo et al. (2000) on young and older adults, there were no 
differences between high or low scores on the UCLA Loneliness scale and their healthy lifestyle 
behaviors (e.g. exercise, use of tobacco and alcohol). However, nonlonely individuals were 
better at reducing stress than lonelier individuals. Stress can exhibit hmmful side effects to 
internal organs and can cause lonely individuals health to rapidly deteriorate compared to their 
nonlonely counterparts (Cacioppo, 2003). 
Research provides evidence that the concept of social support lowers morbidity and 
mortality rates in oncology populations, cerebrovascular populations, and cardiovascular 
populations (Uchino, 2006). There are well-supported associations between the presence of 
supportive, nurturing relationships and positive health outcomes (Berkman, 1995; House, Landis, 
& Umberson, 1988; Uchino, Cacioppo, & Kiecolt-Glaser, 1996). Moreover, there is a complex 
linkage between health and social networks, suggesting that social networks may play a key role 
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in individuals' well-being. However, reliable and valid survey measures are lacking. In a meta-
analysis conducted by Pinquart & Duberstein (2010) on social networks and cancer mortality, 
perceived social support, network size, and marital status were associated with decreases in 
relative risk for mortality. Still, there are mixed findings for whether perceived social support, 
network size, and marital status play a role in reducing mortality (De Boer, Ryckman, Pruyn, & 
Van den Borne, 1999). The lack of consensus among findings may be partially due to 
methodological inconsistencies and survey measures, which may be measuring the wrong 
construct. 
The broad based model of potential pathways linking social support to physical health 
has two main pathways: (1) behavioral process and (2) psychological process, both influencing 
mortality and morbidity (Berkman et al., 2000; Cohen, 1988; Gore, 1981; Lin, 1986; 
Thoits, 1995; Umberson, 1987). Refer to Figure 1. 
The focus of the first pathway is based on behavioral processes, including adherence to 
medical regimens and health behavior as constructed by social control and social identity theory 
(Lewis and Rook, 1999; Umberson, 1987). When patients experience positive social support, this 
may directly or indirectly facilitate health-promoting behavior. However, not all social support 
encourages healthy behavior, with some encouraging negative behavior (see reviews by Burg 
and Seeman, 1994; Wills and Yaeger, 2003). 
The focus of the second pathway is based on psychological processes, which are 
associated with appraisals, emotions or moods, and feelings of control (Cohen, 1988; 
Gore, 1981; Lin, 1986). Evidence supports the relation between social support and these 
Cu 
psychological processes. Currently, only mediating models are significant, lacking a direct 
relation between health outcome variables and psychological processes. Moreover, these 
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behavior and psychological pathways may have a reciprocal influence on the processes of social 
support, indicating that individuals who experience psychological distress may alter their 
perception of social support and contribute to a negative social interaction (Alferi et al., 2001; 
Coyne, 1976). This concept supports the Loneliness Model (Cacioppo & Hawkley, 2009; 
Cacioppo, Hawkley, Ernst et al., 2006), in that lonelier individuals who view their environment 
as more threatening, expect greater negative social interactions. 
Additionally, there are two important components of the model which are the proposed 
links to and from disease morbidity and disease mortality. First, the link associated with disease 
morbidity signifies the importance of the potential role of social support and its part in the 
development of diseases. The second link is a feedback loop between disease morbidity and 
social support, indicating the various challenges diagnosed individuals face and how this impacts 
their social network (See Figure !).According to Bolger et al. (1996) after diagnoses, individuals 
tend to reach out to close social networks as sources of support. Mixed results are associated 
with coping in overwhelming situations, with some individuals withdrawing from their social 
network to cope (Bolger et al., 1996), while other individuals see the overwhelming situation as a 
time to prosper in their personal relationships (Holahan & Moos, 1990). 
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Loneliness, Hypothalamic-Pituitary Adrenocortical Axis, and Immune Function 
There are multiple biobehavioral pathways that affect brain-immune system outcomes. 
The major mediating physiological factors which affect clinical outcome are catecholamines, 
glucocorticoids, inflammation, angiogenesis, and cellular immune function (for reviews refer to 
Knight, Lyness, Sahler, Liesveld, & Moynihan, 2013). In the current paper, the focus is on 
glucocorticoids and cellular immune function. 
The hypothalamic-pituitary-adrenocortical (HP A) axis mediates behavioral and 
physiological changes and adaptations through regulation of production and release of 
corticosteroid (Denver, 2009 & Schulkin, 2011 ). The HP A axis is activated by the hypothalamus, 
which secretes corticotropin-releasing hormone (CRH). CRH stimulates the anterior pituitary 
gland, releasing adrenocorticotropic hormone (ACTH). The distributing ACTH releases cortisol, 
which acts as the main regulator of the adrenal cortex. 
The HP A axis acts as an important part of transforming physiology and behavior to 
promote energy, immune, and survival needs (Hawkley, 2012). In social species similar to 
humans, the HP A axis plays a role in physiological and behavioral mechanisms that sustains 
group structures. (Cacioppo & Hawkley, 2009; Cameron et al., 2009; Silk et al., 2009; 
Waynforth, 2011). As a result, social isolation in social species is a stressor which regularly leads 
to increased levels of cortisol (Cacioppo et al. 2011). Researchers have provided evidence that 
loneliness effects HPA functioning in older populations (Hawkley & Cacioppo, 2010; Luo, 
Hawkley, Waite, Cacioppo, 2012). 
A type of a white blood cell, lymphocytes, has glucocorticoid receptors. The 
<• 
glucocorticoid receptors regulate a variety of functions of the lymphocytes. These functions 
include increasing lymphocyte production, recirculating lymphocytes through the blood and 
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lymph systems, and producing cytokines (small proteins that are important in cell signaling) 
(Ebrecht et al., 2000). Cole (2008) reported loneliness differences that are in sensitivity to 
glucocorticoid feedback focuses on the basic logic that exposure to glucocorticoids modifies the 
distribution of white blood cells in transmission. Mainly, an increase in cortisol production 
increases the circulating neutrophil percentages, decreasing circulating percentages of 
lymphocytes and monocytes. Thus, there is a greater ratio of neutrophils to monocytes and 
neutrophils to lymphocytes with higher levels of cortisol. 
White blood cell (WBC) count is a clinical marker of inflammation and elevated WBC's 
are associated with mortality (Weiss, Segal, Sparrow, & Wager, 1995), cancer (Edinger, 
Muntner, & Helzlsouer, 2004), cerebrovascular (Brown et al., 2004), and cardiovascular 
mortality (Margolis, et al., 2005). White blood cell count is an independent predictor for 
cardiovascular and cerebrovascular events (Brown et al., 2004; Wheeler, Mussolino, Gillum, & 
Danesh, 2004) and a negative prognostic factor in congenital heart disease patients (Brennan et 
al., 2003). A low lymphocyte count of eight percent or less of the WBC count and lymphocytes 
that have migrated into a tumor site (Alvaro-Naranjo et al., 2005; Schreck et al., 2009) are 
negative prognostic factors for survival in classical Hodgkin's Lymphoma (Hasenclever & Diehl, 
1998). 
Accordingly, oncology researchers are investigating lymphocyte/monocyte ratios (Porrata 
et al., 2012; Porrata et al., 2013), neutrophil/lymphocyte ratios (Chua, Charles, Baracos, & 
Clarke, 2011 ), and absolute monocyte counts at baseline of bone marrow transplants, day before 
chemotherapy, and at day 100 post bone marrow transplant to predict overall survival rate and 
'71:1 
progression rate in oncology patients. When the absolute neutrophil count to absolute 
lymphocyte count (N/L) ratio was greater at baseline there was an association with worse overall 
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survival in oncology patients (Chua et al., 2011; Halazun et al., 2008). Moreover, Azab (2008) 
determined that a larger N/L ratio is a predictor of greater mortality rates in breast cancer 
patients. In general, these results indicate that higher N/L ratios are associated with poorer 
survival rates in oncology populations. Additionally, elevated absolute neutrophil counts and 
absolute monocyte counts were associated with poor survival (Schmidt et al., 2005). 
Loneliness and Hematology Oncology Population 
In oncology populations, numerous psychosocial factors significantly affect the progress 
of cancer through biobehavioral pathways (Antoni et al., 2006; Cosanzo et al., 2011 ). Various 
researchers have identified several psychological processes as possible predictors of cancer 
progression, including mood, social support, stress, optimism, loneliness, and socioeconomic 
status (Cosanzo, 2011, Lutgendorf & Sood, 2011; McGregor & Antoni, 2009). 
A common cancer group that is frequently treated with hematopoietic stem cell transplant . 
(HSCT) and blood or bone marrow transplants (BMT) are hematological malignancies. 
Researchers are uncertain of the biobehavioral pathway, however previous research has indicated 
there is an association among psychosocial factors and HSCT outcomes (Hoodin et al., 2006). 
Minimal research has been pursued in psychoneuro-endocrinology or psychoneuro-immunology 
due to complexity in endocrine and immunological changes during HSCT, despite high 
psychological and immunological vulnerability (Costanzo et al., 2012). 
In 2010, over 8000 allogeneic bone man·ow transplants and more than 9000 autologous 
bone marrow transplants occurred in the United States (Center for International Blood and 
Marrow Transplant Research, 2012). The most common diseases are multiple myeloma followed 
<:"r. 
by non-Hodgkin's lymphoma and acute myeloid leukemia. 
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Hematopoietic stem cell transplant and BMT entail an obliteration or near-complete 
ablation of native marrow with extremely high doses of chemotherapy, leaving patients with 
severely immunocompromised systems. There are two main types oftransplants: (1) autologous 
- patient provides bone marrow or stem cells for self and (2) allogeneic - bone marrow or stem 
cells are provided from a matched donor. Even though direct investigation lacks, BMT treatment 
may encounter greater levels of distress than other cancer treatments (Knight et al., 20 13). 
Depending on the type of transplant and institutional practice and complications, HSCT may 
involve extended periods of isolation, possibly leading to psychological disorders such as anxiety 
and depression (Sasaki et al., 2000). 
There is inconsistent support on the relation between psychosocial variables, transplant 
related stressors and prior transplant psychological dysfunction (Hoodin et al., 2006). In a review 
of 19 research studies conducted by Hoodin et al. (2006), five of the studies resulted in no 
relation between negative emotion and survival; seven studies determined that individuals who 
experience greater negative emotion is associated with poorer survival rate, and five other 
research studies support positive emotion and pre-transplant optimism, hopefulness, and social 
support were positive predictors for longer survival. 
Prior to a bone marrow transplant, conditioning or a preparative regimen occurs. Patients 
undergo several days of chemotherapy and/or radiation to destroy cancerous cells and bone 
marrow cells (American Cancer Society). This process destroys the immune system, leaving the 
patient vulnerable to infections. After conditioning, patients are in isolation between two to four 
weeks. Within the hospital, they are housed in private rooms with specialized filtered air, 
<:::r. 
specialized diets, and restricted visitor access. Oncology staff, family, and friends must wash 
hands, wear protective gloves, gowns, and masks when entering a patient's room, to reduce the 
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spread and exposure to bacteria and viruses. The patient may experience perceived social 
isolation, psychological stress, and emotional stress during the isolation period and recovery. The 
recovery process is unstable with patients feeling great one day and ill and nauseas the next day. 
After the transplant, the patient's immune system is weak, with low white blood cell counts, 
lacking full immune protection against everyday viruses and bacteria. Contact with the general 
public is usually prohibited unless a mask is worn (American Cancer Society). 
After a bone marrow transplant, there is a certain period during patient recovery where 
susceptibility to infections is greater. During the first six-weeks ofBMT post-transplant, severe 
neutropenia and mucosal damage can occur, contributing to epidermis infections and harmful 
gastrointestinal organisms. Around two to three months post-transplant, humoral and cellular 
immunodeficiency remains a significant consideration (Knight et al., 2013). Cellular immunity 
fights against a virus with the assistance ofT-helper lymphocytes (Th1 cells), producing specific 
cytokines that activate T -cytotoxic cells and natural killer cells. Humoral immunity responds 
against parasites and bacteria with the support ofT-helper lymphocytes (Th2 cells), which 
produce different cytokines that specifically activate B cells and mast cells (Segerstrom, 2006). 
After three months, during the late recovery period, there is a reoccurring risk for viral 
reactivation, bacterial infection, and fungal pneumonia (Knight et al., 2013). 
In addition to viruses and infections, there is still a significant risk for infections post-
transplant. The biological consequences of psychosocial process are possibly important to the 
BMT/HSCT population because activation ofbiobehavioral pathways affect neuroendocrine 
function and contribute to the activity of viruses and regulation of immune response (Antoni et 
<c 
al., 2006). Stress hormones influence various viruses (Cohen et al., 1993; zur Hausen, 1991) 
which are significant causes of mortality and morbidity after BMT/HSCT (Boeckh et al., 2003). 
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More research is needed to investigate the relationship between neuroendocrine 
components of loneliness in BMT populations. The major goal of the current research is to 
investigate the neuroendocrine implications of loneliness in BMT patients throughout 
hospitalization and the recovery period. Another goal is to determine if loneliness experienced 
throughout hospitalization and loneliness in general are predictors of quality life at six-month 
post-transplant. 
Hypothesis 1: Individuals who experience greater amounts of hospital loneliness will 
experience poorer overall quality oflife at six-month post-transplant. 
Hypothesis 2: Individuals who experience greater amounts of general loneliness will 
experience poorer overall quality oflife at six-month post-transplant. 
Hypothesis 3: When individuals experience more loneliness during hospitalization, their 
neutrophil to lymphocyte ratio will be greater 30 days after bone marrow transplant. 
Hypothesis 4: Patients who experience greater amounts of loneliness during 
hospitalization will have a higher neutrophil to monocyte ratio 30 days after bone marrow 
transplant. 
Method 
The current study is part of a larger research study titled, "Complementary and 
Integrative Medicine Use and Disclosure in Blood and Marrow Transplant Patients." Two 
questionnaires were added to the original survey including the UCLA Loneliness Scale Version 
3 and CARE measure. The main focus of this study is measures of loneliness and psychological 
and physical functioning outcomes. 
'C<: 
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Participants 
One hundred and thirty one surveys were mailed to participants who endured a blood or 
bone marrow transplant at the Mayo Clinic of Jacksonville. Forty-one participants returned a 
completed survey and three participants completed the survey without a returned consent form, 
totaling 38 participants. The average age of the participants was 60 years old (SD = 10.86), 
ranging from 25 years of age to 75 years. Over half were female (55.3%, n = 21), Caucasian 
(84.2%, n = 32), manied (81.6%, n = 31 ), and completed university or graduate level education 
(55.3%, n = 21). Close to 40% reported a household income greater than $60K (n = 15); most 
lived in their current housing anangement for more than five years (92%, n = 35), and lived with 
spouse/partner (60.5%, n = 23) and/or children (23.7%, n = 9) at six-months post-transplant. 
The majority of participants completed an autologous transplant (86.8%, n = 33) and 
were diagnosed with Myeloma (60.5%, n = 23). Half of the participants acquired at least one 
infection during transplant (n = 19). At six months post-transplant, over half of the participants 
reported their current health to be Good, Very Good, or Excellent (78.9%, n = 30), did not have 
other major medical issues (57.9%, n = 22), were not readmitted to the hospital (92.1 %, n = 35), 
or did not have a recurrence of diagnosis (76.3%, n = 29). However, over half reported currently 
receiving some sort treatment (52.6%, n = 20). 
Participants' average length of stay in hospital was 22 days (SD = 6.67) ranging from 14 
days to 50 days, with the absolute neutrophil engraftment averaging 11.22 days (SD = 2.00), and 
platelet engraftment averaging 17.84 days (SD = 3 .16). Loneliness reported during 
hospitalization (M = 35.01, SD = 10.85) was higher than general loneliness (M= 32.50, SD = 
<:r. 
10.61), t(37) = 2.12, p < .05. Comparing bone marrow transplant participants' loneliness levels 
to the literature indicate somewhat lower levels of loneliness than college students and nurses (M 
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= 40.08, SD = 9.50; M = 40.14, SD = 9.52, respectively) and greater levels of loneliness than 
elderly population (M = 31.51, SD = 6.92) (Russell, 1996). 
Average white blood cell (WBC) ratios at 30 days after the bone marrow transplant were 
obtained, including neutrophil to lymphocyte (N/L) and neutrophil to monocyte (N/M) ratios. 
They were calculated by gathering WBC data within three days before and after day 30 and 
averaging the levels for neutrophils, lymphocytes, and monocytes. Ratios were calculated using 
the averaged levels over the seven day range. On average, the neutrophil to lymphocyte (N/L) 
ratio at 30 days post-transplant was 4.24 (SD = 10.11), ranging from .16 to 63.83. The neutrophil 
to monocyte (N/M) ratio 30 days after bone marrow transplant was 4.18 (SD = 2.84), ranging 
from 1.30 to 15.61. 
A N/L ratio greater than or equal to 3.1 is considered to be elevated, indicating a greater 
risk for mortality (Chua et al., 2011; Halazun et al.; 2008) and loneliness is associated with a 
greater ratio of neutrophil to lymphocyte (Cole, 2008). Our N/L ratio was above the average. 
McQuellon et al. (1997) reported at day 100 for bone marrow transplant patients, on 
average, overall quality oflife was 112.4 (SD = 20.1) and social well-being (M= 23.5, SD = 3.8). 
The current participants overall quality oflife (M= 107.95, SD = 20.77) and social well-being 
(M = 22.66, SD = 4.92) at six-month post-transplant were below the averaged quality oflife and 
social well-being (McQuellon et al., 1997) at 100 days after BMT, indicating our sample is 
experiencing poorer overall quality of life and social well-being. Our sample reported slightly 
above average physical well-being (M= 21.11, SD = 5.40), emotional well-being (M= 18.00, SD 
= 5.07), functional-well-being (M = 17.95, SD = 6.97), and additional concerns about BMT (M = 
Co 
28.23, SD = 5.53). In McQuellon et al. (1997) the average at day 100 of physical well-being was 
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20.8 (SD = 5.1), emotional well-being was 16.4 (SD = 3.2), functional-well-being was 17.4 (SD 
= 5.7), and additional concerns about BMT was 27.2 (SD = 5.7). 
Procedure 
Oncology/Hematology patients were identified through Mayo Clinic of Jacksonville 
Transplant Log. Each participant was over the age of 18 years and received a blood or bone 
marrow transplant. The survey packet was mailed+/- 30 days of the participants' six-month 
post-transplant date and included one survey, two inform consent forms, and one informational 
document. One to two weeks after the mailed survey packet, if the survey was not returned, a 
follow up call was conducted to remind patients about the research study. For study participation, 
a completed survey and one informed consent form was to be mailed to Mayo Clinic of 
Jacksonville. Medical information was obtained through PowerChart at the Mayo Clinic of 
Jacksonville, Florida. 
UCLA Loneliness Scale Version 3 
The UCLA Loneliness Scale Version 3 was used to assess general loneliness as well as 
the patients' loneliness during hospitalization. The original scale was modified with permission 
from the copyright holder, displaying the two set of20 questions in two columns, parallel to one 
another. The modified UCLA Loneliness Scale asked participants to rate their feelings of 
loneliness during their hospital recovery from the transplant and how the participant generally 
feels (e.g. "During your hospital recovery from the transplant ... How often did you feel alone?" 
and "In general ... How often do you feel alone?"). Feelings ofloneliness were rated on a Likert 
scale from 0 "Never" to 4 "Always". In addition, some items were reverse scored, so that higher 
Cc 
scores on the UCLA Loneliness Scale indicate greater loneliness. For the general population, the 
average loneliness score is 40, ranging from 20 (little loneliness) to 80 (greatest loneliness). 
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Hospital loneliness and general loneliness were computed as two separate scores. The internal 
consistency for the UCLA Loneliness Scale Version 3 is very reliable with Cronbach' s a ranging 
from .89 to .94 and a test-retest reliability ofr = .73 (Russell, 1996). For the current study, 
reliability was strong for both loneliness scales (Hospital Loneliness Cronbach's a= .93; General 
Loneliness Cronbach's a= .94). 
Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT -BMT) Scale 
The FACT-BMT is a validated, cancer specific quality of life instrument, measuring four 
well-being subscales (physical, social/family, emotional, and functional) and a bone marrow 
transplantation specific subscale (additional concerns). The questions were rated on a four-point 
Likert scale from 0 "Not at all" to 4 "Very much". Some questions were reversed scored, 
indicating a higher score denoting better functioning (ranging from 0 to 148). Instructions on 
handling missing data and calculating subscale and summary scores were followed according to 
the recommendations ofMcQuellon et al. (1997). Reliability for the FACT-BMT scale and 
subscales ranged from Cronbach's a's of0.86 to 0.89, with the BMT subscale ranging from 0.54 
to 0.63 (McQuellon et al., 1997). 
For the current study, reliability was strong for the physical well-being (Cronbach's a= 
.87), social well-being (Cronbach's a= .87), and functional well-being (Cronbach's a= .86) 
subscales. Moderate reliability was found for the emotional well-being subscale (Cronbach's a= 
.67) and additional concerns about BMT subscale (Cronbach's a= .72). 
Immunological Components 
White blood cell (WBC) counts (i.e., absolute neutrophil count, absolute monocyte count, 
<::c 
and absolute neutrophil count) were extracted from each patient's medical file through 
PowerChart at day 27 to day 33 after the bone marrow transplant. Two WBC ratios were 
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calculated: (1) ratio of neutrophil to lymphocyte was determined by dividing absolute neutrophil 
count into absolute lymphocyte count (N/L) and (2) ratio of neutrophil to monocyte was 
determined by dividing absolute neutrophil count into absolute monocyte count (N/M). WBC 
ratios have been associated as predictors of overall survivor in cancer populations and indicators 




Several analyses were conducted regarding the association of hospital loneliness, general 
loneliness, and overall quality of life with categorical demographic and health variables. The 
results of these analyses are summarized in Table 1. 
Hospital Loneliness 
Married participants experienced less hospital loneliness than non-married participants, 
F(1, 36) = 5.84,p < .05. Hospital loneliness was not associated with race, age, education level, 
household income, sex, living arrangements, type ofBMT, disease, current prescription use, nor 
currently receiving treatment. Moreover, it was not associated with physical well-being, 
emotional well-being, additional concerns about BMT, number of infections, managing 
transplant symptoms, length ofhospital stay, neutrophil/lymphocyte ratio at day 30 after 
transplant, neutrophil/monocyte ratio at day 30 post-transplant, lymphocyte/monocyte ratio at 
day 30 post-transplant, days to absolute neutrophil count (ANC) engraftment nor days to platelet 
(PLT) engraftment,p's > .13 to .76. Participants who smoked in the past month reported greater 
r:, 
amounts ofloneliness than individuals who did not smoke, F(1, 36) = 16.08,p < .0001, although 
only three people reported smoking. 
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Hospital loneliness was significantly positively correlated with general loneliness [r (38), 
= . 77, p < .0001] and problems managing symptoms over the past six months. Hospital 
loneliness was significantly negatively correlated with social well-being, functional well-being, 
and overall quality oflife (refer to Table 2 for correlations). Hospital loneliness did not 
significantly predict physical well-being, emotional well-being, additional concerns about BMT, 
number of infections, managing transplant symptoms, length of hospital stay, days to ANC 
engraftment nor days to PLT engraftment, and therefore these criterion variables were not used 
in further multivariate analyses. 
General Loneliness 
Participants who are not married experienced greater amounts of loneliness overall than 
married participants, F(l, 36) = 6.08,p < .013. General loneliness was not associated with race, 
education level, age, household income, sex, living arrangements, type ofBMT, disease, 
currently taking prescribed medication, currently receiving treatment, number of infections, 
length ofhospital stay, days to ANC engraftment, nor days to PLT engraftment,p's > .06 to .98. 
Participants who smoked in the past month reported greater amounts of loneliness than 
individuals who did not smoke, F(1, 36) = 8.77,p < .01, although only three people reported 
smoking (See Table 1 ). 
General loneliness was negatively correlated with social well-being, functional well-
being, and overall quality oflife (refer to Table 2 for correlations). General loneliness did not 
significantly predict physical well-being, emotional well-being, additional concerns about BMT, 
number of infections, length ofhospital stay, days to ANC engraftment or days to PLT 
Co 
engraftment, and therefore was not used as criterion variables in multivariate analyses. 
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Overall Quality of Life 
Participants who did not smoke in the past month reported greater overall quality of life 
than individuals who did smoke, F(l, 36) = 6.64,p < .05. Overall quality oflife was negatively 
correlated with problems managing symptoms (refer to Table 2 for correlations). Overall quality 
of life was not associated with race, age, education level, marital status, household income, sex, 
living arrangements, type ofBMT, disease, currently taking prescribed medication, currently 
receiving treatment, number of infections, length of hospital stay, days to ANC engraftment, nor 
days to PLT engraftment,p's > .18 to .99. 
Infections, Symptoms, and Hospital Stay Bivariate Relations 
Several analyses were conducted regarding the association of total infections, problems 
managing symptoms, and length of hospital stay with categorical demographic and health 
variables. The results of these analyses are summarized in Table 3. 
Total Infections 
Participants who were married developed more infections according to medical records 
than non-married participants F(l, 36) = 10.50,p < .01. Total number of infections were greater 
for participants who were living with a spouse/partner and or children F(l, 36) = 8.3l,p < .01. 
Myeloma diagnosis was associated with fewer infections compared to other diseases F(l, 36) = 
5.96,p < .05 (See Table 3). 
Total number of infections was not associated with race, age, education level, household 
income, sex, nor type of BMT. Those patients currently taking prescribed medication, currently 
receiving treatment, or smoked in the past month did not have more infections,p's > .08 to .99. 
<• 
Moreover, total infections was not associated with hospital loneliness, general loneliness and 
overall quality oflife, physical well-being, social well-being, emotional well-being, functional 
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well-being, or additional concerns about BMT,p 's >.23 to .97. Therefore, the number of 
infections was not used as an outcome in further multivariate analyses with loneliness as a 
predictor. 
Problem Managing Symptoms 
Self-reported problems managing symptoms were not associated with any of the 
demographic or health variables,p 's >.10 to .91. Problem managing symptoms was positively 
correlated with hospital loneliness [r(38) = .38,p < .05] and negatively correlated with overall 
quality oflife [r(38) = -.56,p < .0001], physical well-being [r(38) = -.56,p < .001], functional 
well-being [r(38) = -.44,p < .01], and additional concerns about BMT [r(38) = -.61,p < .0001]. 
Additionally, problems managing symptoms were positively associated with neutrophil to 
lymphocyte ratio [r(38) = .32,p < .05], and neutrophil to monocyte ratio [r(38) = 35,p < .05]. 
Length of Hospital Stay 
Length of hospital stay was not associated with any of the demographic or health 
variables. Also, length of stay was not associated with hospital loneliness, general loneliness and 
overall quality oflife, physical well-being, social well-being, emotional well-being, functional 
well-being, or additional concerns about BMT, p 's > .06 to .92. Therefore length of stay was not 
used in further analyses. 
Engraftment Bivariate Relations 
Several analyses were conducted regarding the association of absolute neutrophil count 
(ANC) engraftment and platelet engraftment with categorical demographic and health variables. 
The results of these analyses are summarized in Table 4. 
<:"<1 
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Days to Engraflment 
Days to ANC engraftment was not associated with any of the demographic or health 
variables, nor were there significant correlations between the variables, p 's > .16 to . 97. Days to 
PL T engraftment was not associated with any of the demographic or heath variables, nor were 
there significant correlations between the variables, p 's > .17 to .98. Therefore days to ANC 
engraftment and PLT engraftment was not used for further analyses. 
White Blood Cell Bivariate Relations 
Several analyses were conducted regarding the association of neutrophil to lymphocyte 
ratio and neutrophil to monocyte ratio with categorical demographic and health variables. The 
results of these analyses are summarized in Table 5. 
White Blood Cell Ratios Averaged Day 30 Post-Transplant 
Averaged neutrophil to lymphocyte (N/L) ratio was positively associated with the 
averaged neutrophil to monocyte (N/M) ratio [r(38) = .42,p < .01] and problems managing 
current symptoms [r(38) = .33,p < .05]. Additionally, individuals who underwent an allogeneic 
bone marrow transplant had greater N/L ratio 30 days after the transplant than autologous bone 
marrow transplant patients, although there were only three allogeneic transplants (See Table 5). 
Neutrophil/monocyte ratio was positively related to problems managing current 
symptoms [r(38) = .34,p < .05] and negatively associated with overall quality oflife [r(38) =-
.53,p < .001], physical well-being [r(38) = -.41,p < .05], emotional well-being [r(38) = -.37,p < 
.05], functional well-being [r(38) = -.42,p < .01], and additional concerns about bone marrow 
transplant [r(38) = -.57,p < .0001]. (Refer to Table 5). 
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Multivariate Analyses 
Hospital Loneliness 
Hierarchical linear regression analyses were used to investigate if hospital loneliness is a 
predictor of overall quality oflife (QOL) and problems managing symptoms. Preliminary 
analyses were conducted to ensure no violation of assumptions of normality, linearity, 
multicollinearity and homoscedasticity for all analysis. A coiTelation matrix with variables 
included in analyses are summarized in Table 6. For all regression analyses, marital status was 
entered into Step 1 and hospital loneliness was entered into Step 2. For a summary of analysis 
refer to Table 7. 
Hospital loneliness explained 14.4% of the variance in overall quality of life, after 
controlling for marital status, F change (1, 35) = 6.08,p < .05. The total variance explained by 
hospital loneliness and marital status was 17.0% (p < .05), with the full model significantly 
predictive of overall quality oflife, F (2, 35) = 3.59,p < .05. Examination of Beta coefficients 
indicated that hospital loneliness was the only significant predictor of QOL in the model, with 
greater loneliness experienced during hospitalization associated with decreased QOL 6 months 
following transplant. 
Hospital loneliness was independently associated with reported problems in managing 
symptoms (/3 = .46,p < .01) and accounted for over 17% (L1R2 = 17.8%) of the variance after 
controlling for marital status, F change (1, 35) = 7.58,p < .01. The total model accounted for 
17.9% (p < .01) of variance and was significant in predicting symptom management issues, F (2, 
35) = 3.81,p < .05. Elevated levels ofloneliness experienced by patients during their hospital 
Cu 
stay were associated with more difficulties in managing symptoms 6 months post-transplant. 
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Further analyses were conducted on overall quality of life to determine which subscales 
were significantly associated with hospital loneliness. Hierarchical linear regression was used to 
investigate ifhospitalloneliness was a predictor of physical well-being, social well-being, 
emotional well-being, functional well-being, and additional concerns about BMT, while 
controlling for marital status. For a summary of analysis refer to Table 7. 
Hospital loneliness was found to be independently associated with functional well-being 
(/J = -.37,p < .05) and explained 11.6% of the variance, after controlling for marital status, F 
change (1, 35) = 4.65,p < .05. The full model was not significantly predictive of functional 
well-being, F (2, 35) = 2.59,p > .05, and marital status only accountep for a very small and 
nonsignificant part of the variance (1.3%, p>.05). 
Marital status accounted for 8.2% (p > .05) of the variances in social well-being, with 
hospital loneliness explaining an additional16.2%, Fchange (1, 35) = 7.49,p < .01, (Total R2 = 
24.4%,p < .01). The full model was predictive of social well-being, F (2, 35) = 5.65,p < .01, 
with only hospital loneliness statistically significant, (/J = -.43,p < .01) in the final model. 
Greater levels of hospital loneliness predicted poorer social well-being at 6 months post-
transplant. 
Hospital loneliness was not found to be independently associated with physical well-
being, emotional well-being nor additional concerns about BMT (p's > .06 to .44). 
To investigate if hospital loneliness is a predictor of immunological functioning 30 days 
after BMT, utilizing white blood cell ratios, a hierarchical linear regression was used. 
Preliminary analyses were conducted to ensure no violation of assumptions of normality, 
<o 
linearity, multicollinearity and homoscedasticity for all analysis. A correlation matrix with 
variables included in analyses is summarized in Table 6. For all regression analyses, marital 
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status was entered into Step 1 and hospital loneliness was entered into Step 2. For a summary of 
analysis refer to Table 7. 
Hospital loneliness was found to be independently associated with neutrophil/monocyte 
(N/M) ratio 30 days after the bone marrow transplant (jJ = .36, p < .05) and explained 11.0% of 
the variance after controlling for marital status, F change (1, 35) = 4.31,p < .05. The full model 
was not significantly predictive of the N/M ratio 30 days after transplant, F (2, 35) = 2.17 p > 
.05, and marital status accounted for a minimal and nonsignificant part of the variance (O.OO%,p 
> .05). Greater loneliness experienced during hospitalization was found to be independently 
associated with elevated ratio of neutrophil to monocyte ratio at 30 days after bone marrow 
transplant. 
Hospital loneliness was not found to be independently associated with neutrophil to 
lymphocyte ratio at day 30 post-transplant (p = .33). 
General Loneliness 
Hierarchical linear regression was used to investigate if general loneliness is a predictor 
of overall QOL and problems managing symptoms. Preliminary analyses were conducted to 
ensure no violation of assumptions of normality, linearity, multicollinearity and 
homoscedasticity for all analysis. A correlation matrix with variables included in analyses is 
summarized in Table 6. For all regression analyses, marital status was entered into Step 1 and 
general loneliness was entered into Step 2. For a summary of analysis refer to Table 7. 
General loneliness explained 22.3% of the variance in overall QOL, after controlling for 
marital status, F change (1, 35) = 10.40,p < .01. The total variance explained by general 
<u 
loneliness and marital status was 24.9%, with the full model significantly predictive of overall 
quality oflife F (2, 35) = 5.80,p < .01. Examination of Beta coefficients indicated that general 
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loneliness was the only significant predictor of QOL in the model, with greater loneliness in 
general associated with poorer overall quality of life six-months following the transplant. 
Further analyses were conducted on overall quality of life to determine which subscales 
were significantly associated with general loneliness. Hierarchical linear regression was used to 
investigate if general loneliness was a predictor of physical well-being, social well-being, 
emotional well-being, functional well-being, and additional concerns about BMT while 
controlling for marital status. For a summary of analysis refer to Table 7. 
Marital status accounted for 8.2% (p > .05) of the variances in social well-being, with 
general loneliness explaining an additional37.4%, F change (1, 35) = 24.07,p < .001 (Total R2 = 
45.6,p < .0001). The full model was predictive of social well-being, F (2, 35) = 14.68,p < .001, 
with only general loneliness statistically significant, (jJ = -.67,p < .001) in the final model. 
Greater levels ofloneliness in general were associated with poorer social well-being at six 
months post-transplant. 
General loneliness was found to be independently associated with emotional well-being 
(jJ = -.38,p < .05) and explained 12.0% of the variance, after controlling for marital status, F 
change (1, 35) = 4.76,p < .05. The full model was not significantly predictive of emotional 
well-being, F (2, 35) = 2.39,p > .05, and marital status only accounted for a very small and 
nonsignificant part of the variance (0.01 %,p > .05). 
General loneliness explained 15.5% of the variance in functional well-being, after 
controlling for marital status, F change (1, 35) = 6.51,p < .05. The total variance explained by 
general loneliness and marital status was 16.8%, with the full model significantly predictive of 
Cn 
functional well-being F (2, 35) = 3.53,p < .05. Examination ofBeta coefficients indicated that 
general loneliness was the only significant predictor of functional well-being in the model, with 
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greater loneliness in general associated with poorer functional well-being at six-months 
following the transplant. 
General loneliness was not found to be independently associated with problems 
managing symptoms at six-months post-transplant, physical well-being nor additional concerns 
about BMT,p 's > .12 to .33. 
Discussion 
Results indicated that whereas general loneliness was associated with quality of life 
(QOL) indicators such as social and emotional well-being, it is not significantly associated with 
problematic symptoms 6 months post-transplant nor immunological outcomes at day 30. 
Experiencing loneliness during the critical hospitalization period in which patients are rebuilding 
their immune system from a transplant is more predictive of continued problems managing 
symptoms six months after the transplant and poorer immunological functioning at 30 days post-
transplant. Both hospital and general loneliness were found to be associated with QOL indicators 
of functional and social well-being. 
Hypothesis one was predicted from previous research on hospital isolation and quality 
oflife (Alpass & Neville, 2003; Berkman, 1995; Freyne et al., 2005; Piadala et al., 2013). 
Hypothesis one was supported in that experiencing greater degrees of loneliness during 
hospitalization was associated with poorer overall quality of life at six months post-transplant. 
Further analyses revealed that social well-being and functional well-being were the most 
impacted components of quality of life. In addition, patients who recalled greater amounts of 
hospital loneliness reported more problems managing symptoms six-months after a bone marrow 
~ I 
transplant (BMT). These results imply that experiencing greater amounts of loneliness at the time 
of hospitalization can have long lasting effects with implications for every day functioning and 
LONELINESS IN BONE MARROW TRANSPLANT PATIENTS 27 
social well-being. This may lead to long-last side effects, creating stress, reducing immune 
functioning, and increasing health complications. Social isolation and loneliness are associated 
with poorer psychosocial well-being and adverse health outcomes (Alpass & Neville, 2003; 
Berkman, 1995; Freyne et al., 2005). According to Pidala et al. (2013) overall quality of life is 
associated with severity of graft-verse-host disease. Patients, who experience severe graft-verse-
host disease and report more negative symptoms, on average, have poorer quality of life than 
patients experiencing a mild graft-verse-host disease. In addition, over time patients who 
reported more severe symptoms had poorer quality of life and reported less daily activities 
(Cohen et al., 2012). The current results further support previous research on the relationship 
between loneliness and poorer quality oflife (Neitzert et al., 1998). 
Researchers suggest that loneliness is associated with both poorer psychosocial outcomes 
and health outcomes (Ernst & Cacioppo, 1999). Hypothesis two was supported in that greater 
general loneliness was associated with poorer overall quality oflife at six months post-transplant. 
Further analyses determined the quality of life components most impacted were social well-
being, emotional well-being, and functional well-being. This indicates that individuals who tend 
to feel lonely do not feel as connected with friends and family members, which is associated with 
difficulty in performing everyday activities. 
Loneliness is associated with depression, anxiety, and stress (Ernst & Cacioppo, 1999) 
which is related with poorer mental health and physical well-being (Cacioppo et al., 2000; Ernst 
& Cacioppo, 1999; Perkins, 1991), such as coping with an illness (McQuellen et al., 1997). Also, 
loneliness is associated with impaired cognitive functioning and cognitive decline over time 
(Gow et al., 2007; Tilvis et al., 2004; Wilson et al., 2007) which may result in difficulty 
completing everyday tasks such as working within or out of the home. Our results further suppoti 
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current literature, indicating that lonelier individuals are associated with poorer emotional 
functioning, overall well-being, and negative health outcomes. 
Moreover, these results support the Loneliness Model conceptualized by Cacioppo, 
Hawk:ley, Ernst et al. (2006). As bone marrow transplant patients experience more loneliness, 
they may perceive their environments as more threatening, expecting greater undesirable social 
interactions, and recalling more undesirable information six-month after the bone marrow 
transplant. These negative social expectations tend to provoke others to behave in a negative 
manner, confirming negative social expectations bone marrow transplant patients have 
preconceived. This relates back to the findings in those individuals who experience more 
loneliness in general is related to poorer social support and poorer emotional coping skills. 
Another model the results support is the broad model based on potential pathways linking 
social support to physical health; see Figure 1 (Berkman et al., 2000; Cohen, 1988; Gore, 1981; 
Lin, 1986; Thoits, 1995; Umberson, 1987). The psychological process pathway indicates social 
support is linked to appraisals, emotions or moods, and feelings of control. Individuals who 
experience psychological distress, e.g. loneliness, may alter their perceptions of social support. 
This contributes to their misperceptions of a negative social interaction (Alferi, et al., 2001; 
Coyne, 1976). Loneliness and a poor social network are related to low quality oflife, (Ekwall, 
Sivberg, Hallberg, 2004) poorer physical well-being, and poorer mental well-being (Ernst and 
Cacioppo, 1999; Gupta and Korte, 1994; Lui, 2007; Perkins, 1991). Loneliness impacts physical 
well-being and this has been linked to immune stress responses and worse cognition over time 
(Luanaigh & Lawlow, 2008). Our results provide further support of the broad based model. As 
<< 
an individual experiences loneliness, poor social support, and poor social well-being, these are 
associated with greater emotional distress and poorer everyday functioning. These outcomes may 
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negatively alter immunological functioning and biological function, in increasing disease 
morbidity and mortality. 
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Previous literature determines that oncology patients who have a stable social support 
system leads to better survival rates, higher quality of life, decreased depressive rates, less post-
traumatic stress disorder symptoms, and decreased psychosocial morbidity (Booth-Jones, et al. , 
2002; Grassi, Indelli, Marzola, et al., 1996; Jacobsen, Sadler, Jenks Kettman, & Altmaier, 2008; 
Lloyd-Williams, & Friedman, 2001: Rodrigue, Pearman, & Moreb, 1991; Widows, Jacobsen, 
Booth-Jones, et al. , 2005). Overall, stable and positive social support throughout the bone 
marrow transplant process has been linked to positive health outcomes (Frick, Ramm, Bumeder, 
et al., 2006; Lim & Zebrack, 2006; Rodrigue, Pearman, & Moreb, 1991). To further support this 
outcome, oncology patients who have relationships with problematic interactions were 
significantly associated with poor emotional and social function (Frick et al., 2006). Moreover, 
some patients feel safer expressing themselves in a support group setting instead of confiding to 
family members. This may occur due to family members being unable to understand the 
physical, social, and psychological impact of the transplant, changes in communication styles, 
changes in values, and patients' fatigue (Sherman, Cooke, & Grant, 2005). Relating back to the 
results, general loneliness is associated with poorer everyday functioning, such as work, which 
may lead to disruption of social support and social connectedness, and poorer emotional 
functioning. 
Loneliness is considered a stressful experience (Hawkley 2003) and potentially a chronic 
stressor, which has negative effects on the immune and endocrine system functioning, increasing 
multiple health issues (Glaser & Kiecolt-Glaser, 2005) and the association with increased 
mortality risk (Luo, Hawkley, Waite, & Cacioppo, 2012). As stated in the Evolutionary Model, 
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(Cacioppo & Hawkely, 2003) when an individual perceives their surrounding environment as 
threatening, survival mechanisms activate, intensifying threats from all relationships. This 
negative social interaction may hinder physiological functioning, interfering with immune 
function. A bone marrow transplant is an isolating and stressful experience which may be 
associated with poorer immunological functioning. 
To further support the current literature, we were interested in determining if there is a 
relationship between loneliness experienced during hospitalization and the neutrophil to 
monocyte ratio 30 days after a bone marrow transplant. Hypothesis four was supported in that 
experiencing loneliness during hospitalization was associated with a higher neutrophil to 
monocyte ratio 30 days after a bone marrow transplant. These results imply that loneliness 
experienced at the time of hospitalization is associated with immunological functioning, which 
may hinder the recovery process and complicating BMT health issues. 
Loneliness has adverse consequences for health and mortality, indicating that greater 
feelings of loneliness are associated with increased mortality risk (Luo, Hawkley, Waite, & 
Cacioppo, 2012). In support of hypothesis four, when individuals experience frequent loneliness, 
as little as one day per week, cortisol is stimulated, increasing circulating concentrations of 
neutrophils and reduces the concentrations of lymphocytes and monocytes (Cole, 2008). 
Furthermore, an individual who experiences subjective social isolation is an independent risk 
factor for variations in leukocyte sensitivity in glucocorticoid regulation (Cole et al., 2007). 
Fauci, Dale, & Balow (1976) recognized that the longest effects of glucocorticoids involve the 
regulation of leukocyte subset composition within circulating blood. When levels of 
<:u 
glucocorticoids are high, they increase the circulating number of neutrophils and decrease the 
circulating numbers oflymphocytes and monocytes (Dale, Fauci et al. 1975; Dhabhar, Miller et 
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al. 1996; Fauci, Dale et al. 1976; Miller, Spencer et al. 1994). Overall, our fmdings are consistent 
with previous literature and models. Individuals who experience greater amounts of loneliness 
during hospitalization have a higher count of neutrophil and a decreased count of monocytes. 
However, our fmdings did not support previous literature, in that individuals who experience 
more hospital loneliness have a greater neutrophil to lymphocyte count 30 days after 
hospitalization. 
In relating back to the broad based model of potential pathways linking social support to 
physical health (Berkman et al., 2000; Cohen, 1988; Gore, 1981; Lin, 1986; Thoits, 1995; 
Umberson, 1987), both hospital loneliness and general loneliness are related to quality of life. 
Specifically, functional well-being, social well-being, and emotional well-being are related to 
loneliness. Loneliness during hospitalization is associated with immunological functioning 30 
days after a bone marrow transplant. This relationship is associated with poorer immunological 
functioning which may be connected to disease morbidity and mortality. However, the direction 
of the relationship cannot be determined due to the correlational design of this study. 
Hypotheses three was not supported. Specifically, loneliness experienced during the 
hospital stay was not associated with a greater neutrophil to lymphocyte ratio at 30 days post-
transplant. These results may be due to the small sample size which is associated with low levels 
of power for the analyses. However, the results were trending in a positive direction, displaying 
more loneliness potentially being associated with greater neutrophil to lymphocyte ratio. 
Jaremka et al. (2012) determined that lonelier breast cancer survivors are associated with 
increased pain, depression, and fatigue symptom cluster after treatment, in comparison with non-
lonely breast cancer survivors. Immune dysregulation has been determined as a potential link and 
connecting health and loneliness, indicating the importance between loneliness and pain, 
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depression and fatigue. Loneliness, pain, depression, and fatigue are associated with serious 
illness or disease, placing individuals at risk for poor health and premature mortality (Becker et 
al., 1997; Hardy & Studenski, 2008; Schulz et al., 2000). Moreover, individuals who reported 
greater loneliness at baseline had higher baseline and stress induced inflammation compared to 
those who felt as if they were more socially connected (Hackett 2012; Jaremka inpress). Our 
results are consistent with previous research, with loneliness during hospitalization being 
associated with more problems managing symptoms, poorer social well-being, and functional 
well-being at six months post-transplant. Experiencing loneliness may hinder the recovery 
process, both physiological and psychological. Minimal research has been conducted on bone 
marrow transplant patients and investigating loneliness during the hospital stay and the 
relationship between psychosocial outcomes and physiological outcomes. 
Researchers need to determine the bidirectional relation between the types of 
psychological change that is required to translate into a biological or physiological change. This 
may lead to dete1mining which psychological interventions are most effective to benefit health 
outcome rates in bone marrow transplant patients. A review by Antoni (2012) emphasized the 
importance of cognitive, behavioral, and social factors as tools of intervention to assist 
adaptation to all stages of cancer survivorship. Four relevant interventions have been 
investigated: (1) exercise; (2) mind-body; (3) cognitive behavioral stress management; and (4) 
psychopharmacologic agents. These interventions as well as others have advantageous effects on 
neuroendocrine and immune function and psychological functioning. Yet, interventions on bone 
marrow transplant populations are limited and lack intensive research due to the complications of 
<:"u 
the transplant (Antoni, 2012). 
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Loneliness is related to stress, anxiety, depression, impaired cognitive functioning and 
cognitive decline (Ernst & Cacioppo, 1999; Gow et al., 2007; Tilvis et al., 2004; Wilson et al., 
2007). By increasing positive social support and reducing feelings of loneliness this may 
improve emotional well-being in regards to the bone marrow transplant process. In having 
positive social support and feelings of social connection bone marrow transplant patients 
psychological and physiological functioning may improve over time. This will result in a 
reduction of negative health outcomes and better at managing symptoms after a bone marrow 
transplant. Moreover, in reducing loneliness and increasing social connection patients, may 
experience both a better bone marrow transplant procedure and quality of life which may lead to 
a greater overall survival rate. 
Limitations 
The study was retrospectively completed, asking participants to recall six-months post-
transplant about their hospital experience. Due to the transplant being an arduous procedure and 
requiring numerous hospital visits from the time of bone marrow transplant discharge to 
completion of survey, recall of hospital loneliness may be inaccurate or misconstrued (Sternberg 
& Sternberg, 2012). General loneliness was identified as how lonely the participants were feeling 
overall. This may be interpreted as a trait since loneliness in general can vary depending on an 
individual's psychosocial well-being. Quality oflife was considered an outcome measure. This 
indicated that quality of life may change throughout the bone marrow transplant recovery 
process. Another limitation was the correlational study design. With marital status being 
significantly correlated with hospital loneliness and general loneliness, we controlled for marital 
status in analyses to assess independent relationships. A third limitation was small sample size; 
(i.e. 3 8 pmiicipants) a greater response rate would increase the statistical power and results. 
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Another limitation was the lack of participant responses and the attrition rate within the bone 
marrow transplant population. The survey was completed by around 33% of the bone marrow 
transplant patients at Mayo Clinic in Jacksonville, Florida. A greater response rate to the survey 
may have occurred if participants completed the survey at the six-month post-transplant follow-
up hospital visit. 
Future research 
Since stress, loneliness, and cortisol modify immune function (Glaser & Kiecolt-Glaser, 
2005) bone marrow transplant patients may be at risk for immune dysregulation pre-transplant, 
during transplant, and post-transplant. Future research should investigate and determine the 
relationship between loneliness and immunological functioning in bone marrow transplant 
patients. When a relationship exists, it may be due to the complicated immune system or 
psychological distress experienced prior to a bone marrow transplant, during a bone marrow 
transplant, and/or after a bone marrow transplant. Additional work should examine other 
psychosocial factors, such as types of social support, quality of social support, and quality of 
social connection during a bone marrow transplant. Moreover, the psychology factors that alter 
immunological outcomes at admission of bone marrow transplant, during transplant, and after 
transplant need further investigation. 
Another future research aim should investigate pre-transplant loneliness and perception 
of overall outcome. A longitudinal design may better predict overall survival and outcome rates 
for bone marrow transplant patients. To predict overall survival and outcome rates, data should 
be collected prior to a bone marrow transplant, day of transplant, time of discharge from bone 
Cu 
marrow transplant, 30 day post-transplant, day 100 after the transplant, six-months after the 
transplant, and one year post-transplant. Another suggestion would be to investigate the 
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caregiver's perception of the BMT patients' hospital and general loneliness and perceived stress. 
Future research may provide a glimpse into how loneliness affects immunological functioning in 
determining overall quality oflife, social well-being, emotional well-being, functional well-
being, and physical well-being, post-bone marrow transplant. 
Conclusion 
Increased overall loneliness is associated with poorer overall quality of life in multiple 
dimensions, in addition experiencing loneliness during hospitalization is associated with 
symptom functioning at six-month post-transplant. Moreover, loneliness during hospitalization is 
associated with a greater neutrophil to monocyte ratio 30 days after a bone marrow transplant, 
indicating there is a relationship between hospital loneliness and immunological functioning 
during the recovery process. Investigation still remains as to whether loneliness and other 
psychosocial factors mediate immunological functioning and how this relation affects overall 
quality of life after a bone marrow transplant. There are multiple biobehavioral pathways that are 
affected by psychosocial factors. This mediating relation needs to be further investigated, 
producing valid and reliable results similar to other oncology populations. Replicablility of both 
positive and negative psychological outcome factors need to be established, which may lead to a 
further understanding of type of social connection and social support, thereby reducing 
loneliness. These research propositions are critical to improving pre-transplant process, reducing 
fears and anxiety recovery from transplant, and life after transplant, contributing to the 
advancement of psycho-oncology research. 
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Table 1: Average Hospital Loneliness, General Loneliness, and Overall Quality of Life by Demographic 
and Health Variables 
Hosnital Loneliness General Loneliness Overall QOL 
Variables n M SD M SD M SD 
Racial Background 
Caucasian 32 33.95 10.44 31.13 9.40 107.54 20.72 
Non-Caucasian 6 40.67 12.226 39.83 14.44 110.17 22.87 
Education 
HS/Partial College 17 35.82 13.75 30.29 11.68 109.50 19.89 
University/Graduate Level 21 34.36 8.09 35.24 9.37 106.70 21.85 
Marital Status 
Married 31 33.11 9.928 30.52 8.87 109.52 20.92 
Not Married 7 43.43' 11.49 41.29' 13.83 101.01 20.01 
Household Income 
< $60K 15 35.80 12.63 33 .67 11.39 110.26 21.77 
> $60K 15 35.97 9.480 32.60 10.99 108.01 20.87 
Prefer not to answer 8 31.75 10.39 30.13 9.22 103.51 20.64 
Sex 
Male 17 35.62 10.34 34.09 12.53 105.89 23.95 
Female 21 34.52 11.47 31.09 8.84 109.62 18.22 
Current Living Arrangements 
Living with spouse and/or 32 33.86 10.64 31.09 9.31 109.00 20.79 
children 
Not Living with spouse and/or 6 41.17 10.74 40.00 14.68 102.35 21.57 
children 
BMT 
Autologous 33 34.08 10.91 32.42 10.84 109.39 20.22 
Allogeneic 3 44.33 11.02 33 .68 13.87 99.72 7.02 
Disease 
Myeloma 23 36.33 11.41 34.48 11 .27 107.95 21.17 
Other 15 33.00 9.98 29.47 9.05 107.95 20.86 
Prescription Medication Regularly 
Yes 36 35.26 4.950 32.58 10.90 106.87 20.80 
No 2 30.50 11.070 31.00 2.83 127.50 3.54 
Currently Receiving Treatment 
Yes 20 34.48 10.04 30.60 8.27 108.26 20.85 
No 17 36.35 11.89 35.29 12.68 108.17 20.83 
Smoked in the Past Month 
Yes 3 55.33"' 7.64 48.33" 10.02 80.33' 15.53 
No 35 33 .27 9.23 31.14 9.63 110.32 19.54 
Note: HS/Partial College = high school, partial college, and/or technical college completed; < $60K = less than $60,000; > $60K 
= greater than $60,000; BMT =bone marrow transplant. 'p < .05; " p < .01 ; "'p < .0001 
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Table 2: Correlati_on Matrix between Variables 
Variables 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 
1. Hospital Loneliness 1.00 
2. General Loneliness .77*** 1.00 
3. Marital Status .37* .39* 1.00 
4. Problem Managing .38* .26 -.03 1.00 
Symptoms 
5. Overall QOL -.41 ** -.49*** -.16 -.56*** 1.00 
6. SWB -.48** -.68*** -.29 -.25 .58··· 1.00 
7. PWB -.16 -.19 -.09 -.56*** .69*** .28 1.00 
8. EWB -.28 -.31 .03 -.19 .65*** .22 .15 1.00 
9. FWB -.36* -.41 * -.12 -.44 •• .87*** .37' .44** .59*** 1.00 
10. AC -.26 -.29 -.13 -.61 *** .87** .36* .69*** .43 ** .68*** 1.00 
11. N/L Ratio .19 -.14 -.09 .36* -.10 .10 .09 -.05 -.23 -.22 1.00 
12. N/M Ratio .30 .16 -.02 .34* -.53*** -.15 -.41 * -.37' -.37* -.42** .s7*** 1.00 
Note: Days until ANC Engraftment =days until absolute neutrophil count engraftment; days until platelet count engraftment; LOS= length of 
stay in the hospital; Overall QOL = overall quality of life; PWB =physical well-being; SWB = sociaVfamily well-being; EWB =emotional well-
being; FWB =functional well-being; AC =additional concerns about bone marrow transplant; NIL Ratio= neutrophiVlymphocyte ratio at day 30; 
N/M Ratio= neutrophil/monocyte ratio at day 30. 'p < .05; **p < .01 ; ***p < .0001. 
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Table 3: Average Number of Infections, Problem Managing Symptoms, and Length of Stay by 
DemograQhic and Health Variables 
Number of Infections Problem Managing SymQtoms Lengj;h of Stay 
Variables n M SD M SD M SD 
Racial Background 
Caucasian 32 1.25 1.00 12.66 6.73 22.81 6.87 
Non-Caucasian 6 .33 .82 9.67 5.96 17.67 3.20 
Education 
HS/Partial College 17 .94 1.03 11.23 6.64 23.48 8.14 
University/Graduate 21 1.05 1.2 12.95 6.68 20.18 3.71 
Marital Status 
Married 31 1.23** .99 12.29 6.99 22.06 4.70 
Not Married 7 .oo·· .00 11.71 5.12 21.71 12.82 
Household Income 
< $60K 15 .80 1.01 11.07 5.91 19.93 3.58 
> $60K 15 1.20 1.01 13.40 6.88 21.80 5.62 
· Prefer not to answer 8 1.00 1.07 12.00 7.86 26.25 10.81 
Sex 
Male 17 1.06 1.03 11.47 6.95 20.47 5.20 
Female 21 .95 1.02 12.76 6.47 23.24 7.56 
Current Living Arrangements 
Living with spouse and/or 
children 32 1.19* .99 12.41 6.91 22.09 4.62 
Not Living with spouse 
and/or children 6 .oo· .00 11.00 5.21 21.50 14.03 
BMT 
Autologous 33 .97 1.01 11.67 6.54 21.67 7.03 
Allogeneic 3 .67 1.15 19.67 3.51 23.67 4.04 
Disease 
Myeloma 23 .70* .97 12.87 5.96 20.35 5.54 
Other 15 1.47* .92 11.13 7.63 24.53 7.62 
Prescription Medication 
Regularly 
Yes 36 1.00 1.41 12.58 6.58 22.03 6.36 
No 2 31.00 1.01 5.00 .00 21.05 6.78 
Currently Receiving 
Treatment · 
Yes 20 1.10 1.20 11.85 5.98 23.50 8.11 
No 17 .94 1.29 12.24 7.55 20.50 4.12 
Smoked in the Past Month 
Yes 3 .67 1.15 17.67 2.89 21.00 4.36 
No 35 1.03 1.01 11.71 6.67 22.09 6.87 
Note: HS/Partial College= high school, partial college, and/or technical college completed; < $60K =less than $60,000; > $60K 
= greater than $60,000; BMT =bone marrow transplant. *p < .05; **p < .01; ***p < .0001 
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Table 4: Dai:s to ANC Engraftment and Dai:s to PLT Engraftment hi: Demogra~hic and Health Variables 
Da_ys to ANC Engraftment Da_ys to PL T Engraftment 
Variables n M SD n M SD 
Racial Background 
Caucasian 31 11.19 2.136 31 17.65 3.251 
Non-Caucasian 5 11.40 .894 6 18.83 2.639 
Education 
HS/Partial College 15 11.33 2.193 16 17.24 3.360 
University/Graduate 21 11.14 1.905 21 17.24 3.360 
Marital Status 
Married 30 11.20 2.156 31 17.81 3.410 
Not Married 6 11.33 1.033 6 18.00 1.414 
Household Income 
<$60K 13 11.85 1.676 14 18.64 2.951 
>$60K 15 11.27 2.219 15 17.27 3.807 
Prefer not to answer 8 10.13 1.808 8 17.50 2.000 
Sex 
Male 17 11.71 2.339 16 17.95 3.025 
Female 19 10.79 1.584 21 17.69 3.420 
RC _Living Arrangements 
Living with spouse and/or 
31 11.26 2.144 32 17.84 3.361 
children 
Not Living with spouse 
5 11.00 .707 5 17.80 1.483 
and/or children 
BMT 
Autologous 31 11.10 2.12 32 18.03 2.978 
Allogeneic 3 12.00 1.00 3 18.33 1.155 
Disease 
Myeloma 21 10.90 2.26 22 17.82 1.842 
Other 15 11 .67 1.54 15 17.87 4.533 
Prescription Medication 
Regularly 
Yes 34 11.21 2.06 35 17.77 3.237 
No 2 11.50 .71 2 19.00 .000 
Currently Receiving Treatment 
Yes 19 11.26 2.16 20 17.20 3.665 
No 16 11.19 1.94 16 18.69 2.358 
Smoked in the Past Month 
Yes 3 11.67 1.16 2 16.50 3.536 
No 33 11.18 2.07 35 17.91 3.175 
Note: Days to ANC Engraftment =days to absolute neutrophil count engraftment; Days to PLT Engraftment =days to platelet 
engraftment; HS/Partial College= high school, partial college, and/or technical college completed; < $60K =less than $60,000; > 
$60K =greater than $60,000; BMT =bone marrow transplant. Two participants never went below ANC of 500 and were not 
used in the analysis. One participant never went below platelet count of20,000 and was not used in the analysis. *p < .05; **p < 
.01; ***p < .0001 
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Table 5: Average Neutrophil/Lymphocyte (N/L) Ratio and Neutrophil/Monocyte (N/M) Ratio at Day 30 
Post-Trans_Qlant by DemograJ2hic and Health Variables 
N/L Ratio N/MRatio 
Variables n M SD M SD 
Racial Background 
Caucasian 32 4.75 10.95 4.16 3.05 
Non-Caucasian 6 1.55 1.21 4.30 1.29 
Education 
HS/Partial College 17 2.30 1.26 3.24 3.43 
University/Graduate Level 21 5.81 13.49 4.95 1.48 
Marital Status 
Married 31 4.68 11.16 4.21 3.10 
Not Married 7 2.31 1.24 4.06 1.19 
Household Income 
< $60K 15 2.53 1.21 3.65 1.23 
> $60K 15 6.11 15.97 4.03 2.70 
Prefer not to answer 8 3.01 2.59 5.47 4.73 
Sex 
Male 17 2.52 2.10 3.84 2.46 
Female 21 5.63 13.45 4.46 3.14 
Current Living Arrangements 
Living with spouse and/or 32 4.67 10.98 4.18 3.06 
children 
Not Living with spouse and/or 6 1.93 .79 4.20 1.24 
children 
BMT 
Autologous 33 2.34 1.57 3.84 2.60 
Allogeneic 3 23.69*** 34.78 5.45 3.10 
Disease 
Myeloma 23 2.57 2.57 4.21 3.02 
Other 15 6.80 6.80 4. 14 2.64 
Prescription Medication Regularly 
Yes 36 4.33 10.38 4.23 2.89 
No 2 2.65 1.10 3.31 1.65 
Currently Receiving Treatment 
Yes 20 2.87 2.44 4.60 3.46 
No 17 5.90 14.96 3.53 1.81 
Smoked in the Past Month 
Yes 3 3.86 1.49 5.26 1.75 
No 35 4.27 10.54 4.09 2.91 
Note: HS/Partial College = high school, partial college, and/or technical college completed; < $60K = less than $60,000; > $60K 
=greater than $60,000; BMT = bone marrow transplant. *p < .05, **p < .01 ; ***p < .0001 
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Table 6: Correlation between Hospital Loneliness, General Loneliness, and Criterion Variables 
in Hierarchical Linear Regression 
Loneliness 
Hos~ital General 
Criterion Variable r(n) p_ r(n) p_ 
Age -.17(38) .31 -.11(38) .49 
Overall QOL -.41 (38). .01 -.50(38)** .00 
PWB -.16(38) .35 -.19(38) .26 
SWB -.48(38)'* .00 -.68(38)*** .00 
EWB -.28(38) .09 -.31(38) .06 
FWB -.36(38)' .03 -.41(38) .01 
AC -.26(38) .11 -.29(38) .08 
Total Number oflnfections -.20(38) .23 -.20(38) .23 
Managing Symptoms .3 8(3 8). .02 .26(38) .12 
DaystoANC .04(38) .84 .03(38) .88 
Days to PLT -.08(38) .66 .09(38) .58 
N/L Ratio .12(38) .48 -.15(38) .39 
N/MRatio .30(38) .07 .16(38) .33 
Note: Overall QOL = overall quality of life; PWB = physical well-being; SWB = social/family well-
being; EWB = emotional well-being; FWB = functional well-being; AC = additional concerns about bone 
marrow transplant; Managing symptoms= problem managing symptoms, Days to ANC Engraftment = 
days to absolute neutrophil count engraftment; Days to PLT Engraftment = days to platelet engraftment. 
N/L Ratio =neutrophil/lymphocyte averaged ratio at day 30; N/M Ratio =neutrophil/monocyte averaged 
ratio at day 30. 'p < .05; **p < .01 ; ***p < .0001. 
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Table 7: Hierarchical Linear Regression of Hospital and General loneliness predicting Quality of 
life and Hospital Variables 
Loneliness 
Hospital General 
Criterion Variables B SEB ~ B SEB ~ 
Overall QOL -.783 .318 -.409* -1.008 .313 -.515** 
PWB -.069 .090 -.139 -.090 .092 -.178 
SWB -.197 .072 -.433** -.309 .063 -.667*** 
EWB -.155 .081 -.331 -.180 .083 -.377* 
FWB -.236 .109 -.367* -.282 .110 -.429* 
AC -.127 .090 -.249 -.146 .092 -.280 
Total Number of Infections -.002 .015 -.024 -.001 .015 -.011 
Managing Symptoms .278 .101 .455** .203 .110 .325 
N/L Ratio .166 .167 .178 
N/M Ratio .093 .049 .357* 
Note: Overall QOL = overall quality of life; PWB = physical well-being; SWB = social/family well-
being; EWB = emotional well-being; FWB = functional well-being; AC = additional concerns about bone 
marrow transplant; Managing symptoms= problem managing symptoms; N/L Ratio= 
neutrophil/lymphocyte ratio at day 30; NIM Ratio= neutrophil/monocyte ratio at day 30. Controlled for 
Marital status. *p < .05; **p < .01; ***p < .0001. 
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SIOtl b~ oa· c-all : The ·~epriOlll t I cthc Rc~ l tlltion De k 3 1 .e fu t :fl 0 . tU U) 
tl e D. n., Buildit ll 
• ••l .r- .tpp•••od::Jn• !1, ! CH I 
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9. Will You Be Paid For Participating In 
This Research Study? 
You will not be p id fos. t kio! p 1t in this smJy .. 
10. What Happens If You Are Injured Or Ill 
Because You Were In This Research 
Study? 
If you b:m: ide effect~ frot'l~ t:lkut~ p;tH in mi~ \ntdy, yo t need to tepottrbt'tl of e 
re~a:eh¢r ano :·~ur rcg\1 lar phy>kk\ll. and you ,.;u be treated ' need: d. M~yo will ~ivc 
medical . en; c for trcatmcn for · ny bad ~i · c effect. from tokiu,=- paJt in I h study. 
:Sue ~cr.ri e~ wal be fitt if not cover-ed by , I c.1hlt pl. OJ' :n<oUJ.l.'l c. l'o :lddiri 11al 
money vill ~ offered. 
11. What Are Your Right. IfY ou Are In 
This Research Study? 
T akin~ p.,rt in i<.~ xc:: ~e<~rt.b ~tu(f; will u t c ngo your righh <~nd benefit-; , 1. ·ix\g p;t.Jt in 
1hi-. tesest b .-,tudy does noj ·~ive you a:l)y special if>~ vi lege;. If you decide to tlot 
p.1rti ,; ipnte iu thi -.rudy. or slQp in the middle f ·I <: udy• uo benefi ts nre «ke (lW~ y 
from y ' · Y:ou do oot ha\·c 1 be in th i rcsc:.1.rc:b tu<ly to receive or ·Qntiuue to rc.:eh·e 
medi i)\ Jre ftom M3.~·o Clinic. 
You will bt told o i:upo t l!\lllll t"\ fu1d tl8S. 0 1 • ny ch.'lll~c '> in tl1c sn d. or pro :dutc thilt 
nu y ftc : t yo • Qr your •.vi llingn-.. s to oorinue in t.be htdy • 
. 12 . \Vhat About Your Pnvacy? 
Autborizntiou To Usc- An1t Dh . ._losc- Prott<kd Hc:~tlth Informntiou 
Yow pi'iv 'i i impo: t t to m. ad we: \\'":ln l to proit ct i1 as nlucb • s po ibk B _ 
signing hi fonu yo11 <~Ulhorizc Mayo Clinic and thQ iu..-~tigalor~ to \l5C .1.11d di~do e 
'll1Y inf'on tu ti 1 r . ted ot coll~ted t t1 th our> ofy ,. F:lrtie1p:niotl i1l tlki~~: ' ~e ' h 
prot~ol. Tht .. in orm.'lrion mi$ht b-:: in differ en p 3<:cs, i.ncludins your ori$i.MI medical 
r~ord . but we \'ill only di lose iJJ onu~ ion dmr i rcla e l tQ this rc ·:t'l.rdt pi o;ol for 
he pmpo ~ lhtcd bc:low, 
oun(l. • &6a t 
C -~&If" HO .\ pj>r6 .-.1: :JitUt !1. : H 
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This in nn.:ui n will be 8iYet om .fot the: pt per moo1t01in~ o the: study~ c:ckin~ the 
• uu1cy of «tdy a n.-,lyzing 111 . rody <I< 1 ond o1het Jltllpo ~ - uec sruy for 1he 
proper ondl.l t .t\J tepoHul~ oithi ~rudy. If ~o;uc: oftl c: itubmutiOt i rc:por cd in 
pub)i~hcd ntedic: lj liJlll'h 01 ien~i.fi c di)~\S!>ion it \\ill be douc inn W<')' tl111t <:1 c;~ uo 
dire:<: }y idemify y u. 
This ini.)rmJtiou lll3Y be: ~iven to other ~s~hc:rs in this ~rudy. includiu~ those: at other 
in titutiou· cOt' ptiv.ate, 1~1e o fc:dcl*ll ~1)\'ettul.c:ot plJtte~ or c:8ulatory. nt ritie in the 
USA Jll o-1h~r \~ttuie. x~ p-ou i'ble tor oven~eing mi· re t.1tcb. Thm~ moy ittclu I.e rue 
Food e~nd Dnt~ Administtotion. dt: 0£6~ f, Hmu~n Rc:~rc:h Prolection<., or other 
ofiicc: wi hiu the DC"Partmeut ofHc:lllth 11nd HumM Sen;c;c;~ . and the: Mnyo linic Office: 
ror Hm n Rese:3t h Pr<1tec:tinn or other Mnyo groups involn·d iu pr-olc:cting re c:ar~h 
~ubjc.;r~ . 
n· tl i i.nfoi1n:uion i~ ~\'c:n out to. 1 yone ont\idc of 1\b:yo the i.nfonn:uion may no 10JI~er 
< pi'OI~.;tcd by fc:<kml priYacy r-cgulution unchll-lY b~ gh•en Olll by e: pc:rwn or entity 
1hn1 receiv~~ ili~ intoouAt!on. How~v~f'. Moyo will t 1.:~ ~~~p~ to bi!lp o1hat prutie~ 
lmd(n ud the need Q keep thi infotntaiion c ufidcntinl. 
TI1i oulhottz tioal lo t~ llllhl t11c c • .d of r c: study. 
The snt y ~ · 1 en<lu.m iJ on dato ha ~en ooU t <.1. h ck d f 6\ lit~d. ld 
alyzcd. So c nnc thi · c u be ycaJ ficr your tud · vi~its hnc cndc . for cKillllJlk, 
thi ould lt pp~n ·fnte re ·uiJs f n~· <ll,:filed witlHl regt ntory ag.~l y liku e 
Food t~nd Drug Administr111i<1n. 
13. What WiU Happen to Your Sa1nples? 
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14. \\Tho Can Ans.\:ver Your Questions? 
- You c-au c-nll ••• -· - -- ff j Oil bii\;- q uesflous o1• r:G nl'~t·ils-At •.• 
:about ... 
P rluclpai.Jun rl,~uor: Puoui!': Q uestion about rbf' Hudr rHrs 
tc- ,·c-u C. Arne-~ , b.D. 11 nd procC'dn rc-~ 
Rt>s£-a a·rh . a·t latecJ hajw·le 01' 
(' lDtr~c-nd('s 
~II ' I'E!5l>:ll'Ch-t-.bt£'d CODCE'l'llS 01' 
• c:omplnin ts 
:\fayo CUulr IRB PbOUi!': Rl&bl ~ of a l'tSl>:u-rb ~ubj~r 
Cse of Protec-ted H ~1rh 
Rc- enrcb .. .,j« t ToJl-FnC': ln fonn~lion 
Ad,·ocate  or any ~~•rc:h-rdntc-d coucC'rns 
or compl:linr~ 
R t sunh Billin2 FloJid:a: BiDing; / lnmunce 
Quesl'lous 
15. Sunu11a1y and EnroHn1ent Signatures 
You OO\'C l>:cn .:~sk<:d t;> t, kc p~ in G rcsco.ro:il. srudy. at ~·l:~yo Cli.uk The 1oiorw.ati.on 
JOO\l tbi snad;• h. bee11 p o\·ided to you to it form you. bout ; i sn 
• I hn~ 1'1: d the:: wl. 1e .::ousc:ur form. illltl U of my uc~tion h •··c: ~en rul :wcr<d 
t u y s tista~t~on. 
• I au so ti~fl c:d that 1 h:.wc: bccu :ii\'cU cuoun infommtion abom the puxp<>Sc, 
1\lelhod>, i kc; 1 m l I pos ible c:ndits of t I e smdy to doddc: ifl '; '. tlt co join. 
• I kno•, thll joining he: lt1dy i-. •:olunt111y nud I ~~~r<c: o joiu the: hl<iy. 
• I kt1 w thai I ~ :ltl • 11 the: uw c: tip a wd rc. c :\.1 b ~ufr at • r~y ri.tne ~·irh . ny 
que ion o.r to d) th c:Ul ,,bout ~ide c: ffc;;t . 
• I ku \' that lo • withdt :m from the · tudy t (b\Y time. 
• I wiH be @'i\'cn . ~ p; of d i <nnplc:tc:d f J n. 
IRa 1 !Hf 0 
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Please sij and date o :ihow rhat j"O 1 .nYc rc.1d all of rhc ''bo\·c ittidd itlcs. Please do not 
~i~1 unlc:ss )Oll hnYc: rc:ad this c:utirc: ~on~cnt folllL lf you do not want to si~u. you dou ·, 
I Yc: to, but i yond ,,.,you C:Ult\Ot paa i ip. tc: l1l ll1 is ac: h ntdy. 
Dtttc: ' Time) 
(Sitntlnuc: of P;nrtidpant 
(Priut«l 
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Mayo Clinic: Office for Human Research Protection 
Contact Lt-Ut-r Tt-mplatt-
Protocol Title: Complementary and Integrative Medicine Use and Disclosure in Blood 
and Marrow Transplant Patients 
lRB #: 10-003464 




{c;ty, State Zip} 
Dear {Mr., .l.tfs, or Mrs.} 
RE:J:. { ftrsL name) {lase name} 
MC". {me ri} 
You are being asked to take part in this research study because you have received a blood 
or marrow transplant. We would like to better understand the frequency and reasons for 
use of complementary and alternative medicine in blood and manow transp.lant patients. 
Additionally,. we would like to better tmderstand whether patients teU their healthcare 
providers about their use of complementary and alternative medicine. 
If you agree to be in the study you will be asked to complete four questionnaires one 
time. The first questionnaire is named the Complementary and Alternati\·e Medicine 
SUI\·ey and asks about your use of complementary and alternative medicines. The second 
questionnall-e is named the Functional Assessment of Cancer Therapy-Blood and Marrow 
Transplantation and asks about your quality of life. The third questionnaire is named 
UCLA Loneliness Scale and. asks about feelings of loneliness. The fourth questionnaire 
is named Consultation and Relational Empathy Measure and asl:s about your satisfaction 
with your relationship with the doctors who cared for you while in ,fue hospital for your 
transplant. It is estimated that these questionnaires will take approximately 15 minutes to 
complete. We have enclosed the questionnaires to complete. If you would like to, you 
may fill it out and retmn in the enclosed stamped em·elope. 
The risks of this research study are minimal. which means that we do not believe that 
they will be any different than what you would experience at a routine clinical visit or 
during your daily life. However, it is possible that some questions you will be asked to 
answer in the study questionnaires may make you feel uncomfortable. Y:ou may choose 
not to answer any questions that make you feeltmcomfortable. 
so 
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This study will .not make your health better. It is for the benefit of research and may aid 
us in helping people in the future by better lmderstanding the frequency and reasons for 
use of complementary and alternati\·e medicine in blood and marrow transplant patients. 
Please tmderstand your participation is voltmtary and you ha\·e the right to withdraw your 
consent or discontinue participation at any time without penalty. Specifically your 
cWTent or future medical care at the Mayo Clinic will not be jeopardized if you choose 
not to participate. 
If you decide to participate please read and sign the consent form and return v.ith the 
questionnaires. An exira copy is included for your records. 
If you have any questions about this research study you can contact me at
If you have any concerns, complaints, or general questions about research or your rights 
as a participant, please contact the Mayo Institutional Reviel'i Board (IRB) to speak to 
someone independent of the research team at or toU free at 
ffyou prefer to ·complete the sunrey o\·er the phone, or if you do not \\ish to participate, 
please indic.ate on the ne.xt page and return this letter since it will make a follow-up 
telephone call unnecessary. Thank you very much for your time and consideration. 
Sincerely 
Steven C. Ames, Ph.D. ABPP 
Principal Investigator 
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RE: {first name} {last name} 
MC#: {me#) 
D I would prefer to complete the smvey over ,the phone. I am ~ndosing the 
Authoriz:ttion to Ust> and Disclost> Protect~d Health Information form only. Please 
<:all me. 
Your name: - ----
Telephone number: (__)_-__ 
Today' s date: _ 1_ 1 
Best time to call: U Morning D Afternoon D E\-ening 
Best day(s) to call: ____ _ 
D I am not willing to participate in this research study. 
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To«Uy's Date: OJ I OJ 11 I I I I 
Day Year 
Birth date: 
l. Wbt n your medicti dia~osi.s., for which you re<eind a BMT? 
2. An you re<tiriD~ uy trutmeat curnatty? 0 No QYe; 
3. Hnt you had a rtcurnact siact yoar Blli? 
QNo 0Yes Date:[D I rn I I I I I I 
Month Day 
J. Do you bn any other EUjor mtdical mats at litis time? 
QNo QYes 
S. Woald yoa say tlut }·our ClllTtDt hrtith is (che<k one): 
0 E-u:~a:.t 0 Vetty ;good 0 Good 0 Fail QPoor 
6. Ethnic :roap (ch*Ck oar): 
Q lfupanitlSp.mi;h•Latmo 0 Not Hi >pam S~sho Luino 
7. RacUl Backuouad (che<k ou): 
0 American Endian or A!askom Nath-e 0 . ·ati\.·e Hawa.ili.J!i1>acific iilmder 
0 .-\sian 0 \Vhite 
0 Black or .o\frican Americom 0 More thAn oce ra<:e (specifj): ------------
8. lbrital Status (cbe<k oar}: 
0 Ne\'er m.mied 0 Divorced 
0 Ctl.tmltly mmied 0 Wedowed 
O~ttd 
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9. \'\ut is your carrtat lirill~ ~rrn~tmtat (chtd::. Ollt) 
0 b.-e alox:.e 0 Live Mth roon:..m.1te who is cot pa.ttner 
0 Live \\-itb spou;;e:.'pmner 0 Lh·e with pareots 
0 Live v.-itb spou.;e/p!l'tn& .mi chi!aen 0 Other (spe-cify): 
0 Live with children (to >p<r.ce..panner) --------------
10. ~ambtr of childrtll ~ 2t homt (tnttr 0 iho11t): I I I I 
11. How Jo~ iD curnat liriD: una.~tmtllt (chtcL: oat): 
0 Less than 1 mooth 0 Two co 5 rem 
0 On! to 6 mor.ths 0 More thln 5 years 
0 'Se\·en months o ~s thaD- yean 
12. Len) of school compltttd (check oat): 
0 l.es; tbm i tb gade 0 Pmial coUeEe or ~ed •tnicil:lg 
0 Co!l!'ge or w:i"re:sil}· grad"Ua -! 0 Junioc High School (ith. 8th. & 9th grade) 
0 Pmial High School (1 O!h or 11th ,grade) 
0 ~School ~te 
0 Gmduate pro!'e»ional training (_mduue degree) 
13. Carnat ·tmploymut sifuatioa (chtclt fht oat box tlut 2pp!ies the most): 
0 Full time at job 0 Seeking wor.k 
0 l>.1rt time at job 0 Retired 
0 On Iea,·e 'aim p.1y 
0 On le.l\·e 'aitbout pay 
Owabled 
U. WJUch cate;ory btst dtscribts your llS1l1) occup2tioa? If you ut llOt currtatfy tmploytd, which utegocy btst 
describes your L-\ST job? (check oat): 
0 Profesiion.a! (e.g... t-!achersi'professon. ouries. Ll\\")'eiS. physicians.. .. r.: engineErs) 
0 ~!.ma,gertAdministntor (e.g .. sabes maJ!;,l,gefi) 
0 Clerical (e.g .. secretarias. cleni. or IIWl ·carriers) 
0 Sales (e;g.. sales pmom .. ~gmti. or brokers) 
0 Senite (e.g~ polK e. cooks. w~tm. oi hairdr.mers) 
0 Skilled Cnfu. Repairer (e.g crupenrers) 
0 Equipn:ent or Veh:cl! Opemor (e.~. trod dri\'ers) 
0 L1bccer (e.g .. maim~e or ooory W()r.ker.) 
0 Farmer (e.~ ownm. Ir.l!lla,ger>. open tori. ·or tenant;) 
0 Membu of the Ir.iliwy 
0 Hon::emaker (aith no Fob outside the home l 
• 
Qomer (p.eas.!de;aibo!) -------------------
Pa~e 3 of:!O 
:usss 
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IS. Which ut~ory best dts<ribts your spouse•s as.W om1p,ation? If your spo~ is aot curnntly tm.ployed, whicb 
cate~ry best describes his.1ber L:\ST job? (cbtck one box): 
0 Profe:s siOIW (e _ ~athm rprofes;.or~ DUrse:s. Ll'i\ym, phy.;icims.. & ~~ws) 
0 ~!an.lger!Admi.ni:ia-aror (e.g .• sa •• ; managers) 
0 Clerical (e.g .• secretaries, cle!ks. or mail c~s) 
0 Sales (e.g sal~ persons. ilgellti, or brokers) 
0 Seni"Ce (e.g_ polXe. cooks. w~ren. or b.Urdres;m) 
0 Skilled Crafu. Rep.1iru (e.~ carpentm) 
0 EqilipD:.ent or Vel:!de Operator (e.: IIUCk dri\'m) 
0 Laborer (e.g .• mai.nr!J!J.I1Ce or f.laOI)' wotkm) 
0 .Farmer (e.g owners. mm.1gers. opeRtors. ox renant;) 
0 ~!~~r of the u:iliwy 
0 Hcm:emaker ('i\ith no • ob ou1side me tome) 
00ther(p.easede>eribe) ------------------------
16. '\\"bat is~ approxillufe :maul p:oss income? (checL: oae box) 
(Rtmtmbt.r aU iaforaution you proridt will rtm.aia compJdtly collfldtnt:W} 
0 les> than .$10.000 0 $40.000 - S59~999 0 Prefer not o an;wer 
0 S!0,00!}- :$19:.099 0$60.000 • SIOO,GOO 
0 $20,000- $39;999 0 Great!I' than $100.000 
17. Approximate u1nl11 p-oss iacomt for your houstbold: (chtcL: oat box) 
(Rtmtmbtr aU iaforautioa: you proridt will r~m completely collfidtntW) 
0 less than S10~000 0 $40,000 • S59.999 0 Prefer not to iUl'i'i\'er 
0 SIO.OOO • $19:999 0$60.000 • 'SlOO.OOO 
0 S20,000 - $39.999 0 Greater than $100.,000 
18. Do you bb prescriptioa mtdicatioa: r~rly? 0. ·o 
IH"ES, \fh2t do you tab? 
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19. Han yo a lud uy troubl~ Dl2U~~ the foDowiD~ symptoms onr til~ p.ut 6 montlu? 
NoProlllta Jast a littlt Uod.tntt 
So at Asb:ad as 
clifficaltr itcubt 
l. Pain 0 0 0 0 0 
•. Nausea 0 0 0 0 0 
3. Fatigue 0 0 0 0 0 
4. SIMp 0 0 0 0 0 
5. Anxiety 0 0 0 0 0 
6. Emorioaal Disttess 0 0 0 0 0 
. Mobility 0 0 0 0 0 
8. IDfectioln 0 0 0 0 0 
9. SlinProbJ>..ms 0 0 0 0 0 
10. Semtl Flmcti011 0 0 0 0 0 
11. Overoill <r Jaliry of life 0 0 0 0 0 
12.0cber: 0 0 0 0 0 
20 • . Dilring your lif~timt, h:an yoa smobd :at le.ut 100 ci:;:antte.s (5 packs or more)? 
QNo QYe; 
IF YES: 
a). F.ow mmy.Ogarene; do.' did you typically smoke each d.ly? 
I I I I (~ dguenes) 
b). Ha\-e you smol:ed ill the pa.;t month. 
0 Yes approx:ima~ I I I I d~~e.; per d.ly 
Q No .• quit bout rn yem OR rn ~thi ago 
c). How n:.my yean in total h.lve you smoked. or if you hal-e quit how llUll}" }-ear> did you .>moke. 
rn (Kumbero!years) 
3~555 
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• • 21. Han you b.Jd any 11coholic drinks m ~put month? 
0No QYes 
IF ~"'ES: 
a). V.lticb o: the :"o.lo'llling 'best de;m'Oei th~ c.:mlber of ako~lic dril:.k; j'OU h.ld in the {>!.it !D)I!.th? 
(cl:ed oc~) (Note: One drink eq.Lili: oc.e 12 oz. can of'be<er. on~ 6 oz. ~~ of wine. or one I oz. :J:.ot 
ofh.lrd quor) 
0 1-3 tii:r.e;a month 0 1 til:ce a da:r 
0 2 time:; a day 
0 3 or more ti.n:.'!i a day 
22. Han you ustd (iD.icif) noa-prtscription dru~ (for uamplt, ID2fijUllJI.I, coclillt) ia tht past month? 
0No 0Yei 
IF YES: 
b). Ho'lll· ~n did yo-.1 me the drug(s) in the past !D)!lth? (chedt one) 
0 1-3 ~a month 0 1 tim! a day 
0 1-3 ti!rei a we>..l: 
0 4-6 til:l:i!i a w~ 
0 2 tim!> a d.ly 
0 3 or more til:ce; a d!y 
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FACT-Bl\IT (\"u"ion 42 
Below is a Ust of statements that other people ·with your illne» have said are imporlmt . . Ple:t:e cirde 




lhl\-e a bck of~··· ····· ··-·--·· ·· .................................. 0 
I ha\-e EUus.e3 ............. ............................. .............. ........... ... . 0 
Because of my physic.al conditioD, I Ju\·e trouble 
Jllli!eting the neEds of nxy funily ................. ........................ 0 
I h.r."e pain ooo , _,.,,, .,,,., · - •••• "• • · -•-•• ••oo• ''"' ' '"""''''' ''' ••oo ••••••• • 0 
I am bothend by s3de effects. of treatmen: ......................... 0 
If~ ill ............................................................................... 0 
lam forced to spend time in bed ........................................ 0 
SOCB.'UFAi\llLY WELL-BEING Not 
:thJl 
If~d.O<.e omyfriends........................................... ......... 0 
I get emotiooal suppon from my family.............. .... ......... . 0 
I get :5Upp0n from my frii!:Dds....... ................................ ...... ·0 
My f:lmily hls xcepced my illn6~ ... ........................ ....•.... 0 
I am .S3ti.sfied \\ith family commtmication abour my 
illDess: .............................. ............................ .... .......... _....... 0 
l f~ clo5e ·o my p3lttl& (or me pmon ~ilo is my II!:.lin 
support) ................................. -.................. ......................... 0 
R~ardi~~ Q/J'CtiT o..<vm~t 1#\ gf Q/~mJI11 c:c:mizy, Jll't;aSq 
al" ..s;w.r ti:q ;'Qifcl,fing ~;rirm. !f-;w prgf'':r r.<>t tr> an.."l!:W i ~ 
p!«JS~ man!. litis box D o:M go ro v.~ Mit ::«firm. 
I am s:uis.fied \\itn my sex life ....... .. ....... ..................... .. ..... 0 
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FACT -BMT (V tl"$ion 41 
Plea~ cirde or m:trk·one .number per line to indicate ~·our respon~e :\'>it applie-; to the pa'it 7 
~· 
EMOTIONAL WELL-BEING Nof A little Souw- Quite V•n-
at <1D. bit lduf a bit macb 
I feel .>3d .......... ...................... ................................ .............. 0 
I am 53tisfied \\itb how l!llll copi!:lg l'fith my .illDess.......... 0 
I am kY:.ing hope ill the fi~t ag3inst my illness.................. 0 
l feel nen·ous .............. _.................................. ....... .............. 0 
I \\'01!1)' about d}ing ....... ····- ···-······· ... ............ .......... .... ....... 0 

















FUXCTIONAL WELL-BEING ~ot A little Som.- Quite Yuy 
d all bit wh.at :a bit mach 
I am. able to w<l'Xk (uxl~ wot:k at home) .......................... 0 1 3 4 
My work (m~ work at bo~) is fulfil~ ..................... 0 I 2 3 4 
I am able to enjoy life .......................................................... () 1 3 4 
I have 3Ccep:ed my illni!Ss ................... .... ................. ........... 0 1 2 3 4 
I am Sleeping well .............................................................. , 0 1 3 4 
I am. ajoying the ·~ I us:willy do fo:r fun ...................... () 1 3 4 
I am c.ootent \\ith the ·qu:ilit)' of my life right 00\\' . .. .. ..... .. .. 0 1 3 4 
P<lgel6of-0 
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F.-\.CT-B:\IT (\"usion 41 
Pl~~ ci.Nle or ~.rk one numhu ~r line to indic3te your re;pono:e a~ it applie-. to the. p:l~t 7 
d."\YS, 
ADDITIONAL CONCER.J.~S Not A little SoiM- Quite Vtrv 
J.t 21! bif what a bit mach. 
I ll» concerned about keeping my job (mchne "W"Ont at 
bo~ne). ... . ........... ..... . . . .. .... . ..... . ...... . ....... . .. . .. . .. .... . . .. ... . . .... .. . ... 0 
I feel distant fran olher people ........................................... 0 
1 
1 
I WOll)r !hac the t:rall.>plmt will DOt\\"Oik... ..... ....... ..•.••.••..... 0 1 
The effects of «ealllleD.t are '\\"One than I bad imagined ..... 0 
I ha\-e .l good 3ppetite ........... ;..................... .... ................... 0 
l like the appearaDCe of my body........................................ 0 
ll!llab.e to get a.'"CIUDd by myself..................... ..... ........... 0 
I get tirM easi!)· ... .................. ... .................. .. .. ....... ....... ....... 0 
131ll interested in sex........................................................... 0 
I ha\-e concerns about my 3bilit}' to .ha\"t! children.............. 0 
I ha\-e confidence in my nmse(s.) ... .... ....... ........... .... ........... 0 
lre~t l.m'ing the bone mmow a:msplant ........................ 0 











I .am able to coocentr:~:te ................................................ ....... 0 1 
I b3\-e frequent coldsi'i.nfections .......................................... 0 1 
My eyesighth bluny .... ...................................................... 0 1 
lam bothered by 3 ch3nge in dle way food •tastes... ....... ..... 0 
l hs\"t! ·tte:mo:rs ..... .... ... .... ........... •.. .... .......... .... .... .... .......... .... 0 
.l 
1 
.I b.a\-e been shon ofbreath .... - .............................. .............. 0 l 
hm.botb.eredbyskinprob!ems (e.g., rub, .itcbin!)........... 0 1 
I .hl\-e trouble \\itb my bov;els ........ _........ .......................... 0 l 
My illness is a persomllwdship for my clo:..e fmlily 
llll"..mbel; ........................................... ................................... 0 1 
The cost of my treaunenr is, a burden on me or my 
f:unily ............... ...... ............. ........................... ..................... 0 1 
......... ... .... 
,._. l U t ~ r 
Page H of_O 
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3 4 
2 3 4 
2 3 4 
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t:CL~ Loneline:.s Scale (Vmion 3) 
lnsm.ccriom: The following :su ement~ de~cribe .bow people sometime> fe.el. Plea~e complete th~ 
fmt cohmm for how you felt dariD~ your reconry from th~ tr:ms plant whil~ in th~ hospital 
and the second co!umn for how you ~u~r2lly feel For H<h stat~mut, ple35e i::ldic3te bon· 
often you feh ,the Pi3Y descnbed by writing a number( l 2 3 or 4) in the space prO\·lded. I!you 
~1 dut the ·question is not applicable to your e:q>erience, please \\-Tire • A. 
Ple3Se w:rile one of me follcming zmmbm on e::tch line corre~-pondiD,g to how ote:l you feel the 
\\"3}' described in the question: KEVER RA.REL Y SO:METiz...lES A.L WA "l'S 
1 2 3 4 
# DllriD~ your hospital reconry from th~ 
'Transplant ... 
1.) __ How often did you feel that you were in 
tune ni!h ,the people around you? 
_.) __ How often did you feel that you b. eked 
comp3llionship? 
3.) __ How often did you feel that there was no 
one )'OU con!d rum to? 
4.) ·--Durillg yourrecO\"ee}" from the tt'm~pJ.ant m 
the hospit3.1, bow den did you feelalo.n~? 
5.) __ F.ow often did you feel pan of a group of 
frl£:1<1;? 
6.) ·--How oftea did you feel that you had a lot in 
common \\i!h ·the people around you? 
7 .) __ Eonr often during your inpatient reco\ "er}" 
period did you fi!.el ·tiut you \\we no longer 
cw:.e to any<X!le? 
S.) __ How often did you feel that your interests 
:Jlld ideas n·e.""e l!l.Ot sh:tred by those ;uOUDd 
you. 
lD g~n~ral .•.. 
__ How o~..n do you ~l that you are in nme 
\\ith the people 3IOund you? 
__ How often do you~ that you lack 
comp:mionship? 
__ How often do you~ that there ii no one 
yon(m tum to? 
__ How often. do you~ alone? 
__ How oft?..11 do you feel pm of a group of 
friend;? 
__ How often do you feel that you ha\·e a lot in 
common wilh the people uound you? 
__ How often do you feel that you ate no !.onger 
close to :myoni!? 
--How often do you feel that your cuere:sts ;md 
ideas are not slured by tbose .around )'OU? 
Pa,ge 18of20 
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Please wri:e one of me folbwing numbm on each l:ine correspondiD.g to how often you feel me 
\\'3)'d~inthequestion: :NEVER RARELY S0!-1ETL\fES ALWAYS 
1 2 3 ~ 
# Darin~ your hospital nconl)·from the 
Trmspb.ut... 
9.) __ While ~ing .an inpatient d.tuUlg your 
tr.mspl:uu reco\'&)' ho\\· often did you feel 
outgoing 3Ild fti:>..ndly? 
10.) __ How often did you feel dose to people? 
11.) __ How often did you feel left out? 
12.) __ Eow ·often did you feel dut your 
rebtioD5hlps with others were o.ot 
meaningful. 
13.) __ How often did you feel mat no one really 
knew you weD? 
14.) __ During your reco\'a}" from ·me tnmsplant 
while in me ho~pilnl, how often did you feel 
isolated .from other;? 
15.) ·--How often did you feel you could tiDd 
coDlp'31liollShip when you \\<-anted it? 
16.) __ ?.ow often did you feel tb3t there \\-ere 
people ~'bo reilly :undmtoodyou? 
17.) __ How often did you feel shy? 
18.) __ \.Vhlle recot-eriugfrom your tt3IlSphiU 3> m 
inpJtient, flo\\' often did you feel thJt people 
were around you oot not 'With you? 
19.) __ Eow often did you feel that there \\"ere 
people you coulchtlk to? 
20.) __ How often did you feel that there \\-ere 
people you coukl rum to? 
__ How often do you feel outgoing and fri:ndly? 
__ How often do you .feel clos.e o people? 
__ How often do you feel !eft ou · 
__ How often do you feel tb:!.t your relationships 
wi!hothen !Ire not m~<rful? 
__ How often do you feel that o.o one re311}· 
blows you well? 
__ How o~..n do you feel is.obted from otht:.""S? 
__ How often do you feel . ·ou em find 
comp;mioasbip when :you v;ant it? 
__ How often do you feel that the.."'e 3I'e people 
who really :under;tand you? 
__ How often do you feel shy? 
__ How often do you (eel th3t people are around 
you but oot wilb you. 
__ How oftm do you~ that the..~ 3I'e people 
you c:m t3lk to? 
__ How .often do you Ceel that the..~ 3I'e people 
you c:m tum to'? 
Y.tge 19 of _o 
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